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CHAPTER I 
INTRODUCTION AND OUTLINE OF INVESTIGATIONS ON 
FAMILIAL STRIO-PALLIDO-DENTATE CALCINOSIS 

STRIO-PALLIDO-DENTATE CALCINOSIS 
1 Definition 
Stno-pallido-dentate calcinosis (SPDC) is the occurence of symmetri­
cal calcifications in the basal ganglia and/or dentate nuclei (2, 
68, 100). Other frequently used names include cerebral calcinosis, 
basal ganglia calcification and lenticulodentate calcification (47, 
61, 68). This disorder has often been called Fahr's disease, suggesting 
a recognizable clinical syndrome (34, 68, 75). However, many SPDC 
patients have been reported who lacked consistent symptoms (16, 
61, 65, 80, 117). Furthermore, Fahr (32) was not the first to describe 
SPDC. It had already been reported in 1856 by Virchow (116). 
2 Neuropathology 
Neuropathological studies on the brain of SPDC patients revealed 
stonelike masses in the basal ganglia and dentate nuclei (68). Under 
the light microscope, drop-like products are visible in and around 
the walls of the arteries, capillaries and veins in the basal ganglia 
and dentate nuclei as well as in the cortex, subcortical white matter 
and radiation of the corpus с allosum (25. 68, S6). Electron microsco­
pic studies have shown that these products can be found within 
the basal membranes of the blood vessels (41). They are composed 
of 140-400 A translucent filaments (acid mucopolvsacchandes) in 
which dark segments of 40-80 A subumts (calcium deposits) are 
found (41). 
X-ray spectrographic methods have shown that the calcium deposits 
are composed of hydroxy-apatite (15, 77). Histochemical techniques 
as well as infra-red, x-rav and laser spectrometry, have demonstra­
ted that elements as well as calcium may be stored: iron, magnesium, 
zinc, copper, manganese, cobalt and silicium (14, 20, 26, 30, 63, 
68). The presence of calcium-containing products in the brain is 
suggested by presence of hematoxylin-positive material (54). However, 
hematoxylin is not a specific calcium identifying agent. When calcium 
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deposits have to be demonstrated, specific calcium identi fying agents 
(alazanne red S) or microprobe techniques have to be used (30, 
67, 68, 93). Hematoxyl in positive material in and around the blood 
vessels, in which calcium can not be demonstrated by specific calcium 
identi fying techniques, is often called "pseudocalcinosis" (10, 54). 
While this "pseudocalcinosis" has been found in about 70% of the 
routine biopsies conducted on the aged (91, 104), i t is seldom found 
in young people (104). This suggests that "pseudocalcinosis" is an 
age related process (68, 77). The neuropathological sign 'pseudocalcino-
sis' probably represents a physiological process. The neuroradiological 
sign "SPDC" however, seems to represent a pathological process. 
1.3 Neuroradiology 
Extensive SPDC can be diagnosed on skull radiograms. The ca lc i f i -
cations in the basal ganglia can be seen on the lateral and P-A 
views. The calc i f icat ion in the dentate nuclei is commonly obscured 
in the lateral views bv the mastoid bones, but is often well demon-
strated in the Towne's projection (92). The incidence of SPDC seen 
on skull radiograms has been studied is a retrospective survey of 
31 years experience at the Mayo Clinics, showing SPDC in 38 patients 
(77). 
Computed tomography (CT) scanning is 5-15 times more sensitive 
in detecting cerebral calcif icat ions than plain skull radiograms 
(61, S>). Nevertheless. SPDC is not Irequently diagnosed with this 
technique. The occurence of calcif icat ions in the basal ganglia varies 
between 0.5 and l.60o; in 0.05oo of these cases calci f icat ions in 
the dentate nuclei are also present (16, 61 , 80, 100). 
The t ime in which SPDC originates is not exactly known. In radiologi-
cal studies the shortest t ime has been reported to be 31 days (102). 
The minimum diameter of a calc i f icat ion which can be detected 
by a CT scanner depends upon many factors. These include the 
properties of the used CT scanner, the amount of calcium in the 
calc i f icat ion, the extent ot the calc i f icat ion and the part ial volume 
effec t (see appendix). 
IA Pathophysiology 
The mechanism of calcification in normal and pathological circum-
stances is related to changes in the tissue cells and extracellular 
matrix (13, 82, 8¡+, 99, 1 \u). 
ΙΑΛ General aspects of mineralisation 
To form insoluble crystalline material, ions or groups of ions must 
come together with sufficient collision energy and with the right 
orientation to form a "critical nucleus", the smallest stable combina­
tion of ions with the structure of the crystalline material that 
can remain in a solution. Nuclcation - formation of this critical 
nucleus - requires energy. Once the critical nucleus is present, 
the addition of more ions and/or ion clusters to the critical nucleus 
requires less energy than the original formation of the critical 
nucleus. Crystal growth or proliferation proceeds by a variety of 
mechanisms and can be facilitated by the presence of critical nuclei 
or materials that resemble с ritical nuclei (epitaxy). Nucleation 
and growth can be promoted by increasing the activity of ion pro­
ducts, and/or by removing inhibitors (13, 99). 
ІА.2 Factors controlling biological calcification 
Despite extensive research in the last ten years, the exact nature 
of the process of biological calcification is not known. There are 
many factors found, that are involved in controlling biological calci­
fication: (13, 81, 84, 99, 114). 
a. One of the first steps in biological calcification is probably the 
transformation of amorphous calcium-phosphate into crystalline 
hydroxy-apatite - Ca (PO,) (OH) -. In this transformation dehydra­
tion plays an important role (114). 
b. Before a tissue calcifies, the extracellular framework must be 
converted from a noncalcifymg to a calcifying matrix. There 
are two main theories on the biochemistry of formation of a 
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calci f iable matrix (1 14). One theory is that calcium is bound 
by tissue proteins and in the process so changes in structural 
conf igu r at ion as to produce a nuc leation center. The other theory 
is that phosphate is bound by collagen so as to produce a nucleation 
center. 
с Specialized tissue cells are involved in the in i t iat ion and control 
of ca lc i f icat ion by means of mitochondria and matrix vesicles. 
The mitochondria provides storage sites for calcium and phosphate. 
Depletion of \TP. i.e. when aerobic glycolysis ceases, is supposed 
to induce the release of calcium and phosphate f r o m the mitochon­
dria. It is also possible that the release of calcium and phosphate 
f rom the mitochondria is secondary to the calc i f icat ion of t r e 
matr ix. Once the in i t ia l mineral is deposited, the decrease in 
oxygen tension and the concomitant cessation of the glycolyt ic 
cycle could result in a release of calcium and phosphate f r o m 
the mitochondria or the cells of calc i fy ing tissues, accelerating 
the mineralization process (13). 
Matr ix vesicles arc phosphate r ich, membrane-bound bodies loca­
lized m the matr ix. r hc\ .> с sometimes formed by intact cells 
or can also appear as a result of cellular degeneration. Their 
membranes contain acid phospholipids which have a high a f f i n i t y 
for calcium. These phospholipids can form complexes with calcium 
and phosphate which promote hydrowapat i te format ion and growth 
(13, 8 1 , 84, 1 14). 
d. The transport and binding of calcium to protein is regulated 
by many enzymes: alkaline phosphatases, acid phosphatases, in­
organic phosphatases, proteases, acid hydrolases and carbonic 
anhydrases (13, 114). 
e. Growth of apat i te deposits can be prevented by many inhibitors, 
including heparin, proteoglycans, pyrophosphates, phlorizin, lodoace-
tate, f luor ide, cyanide, dimtrophenol, beryl l ium, polyphosphates 
and diphosphonates (13, 84, 99, 114). The inhibit ion of calc i f icat ion 
has been studied in calcify ing arteriosclerosis, diffuse interst i t ia l 
pulmonary ca lc i f icat ion, tumoral calcinosis and calcinosis cutis 
(13, 99, 114). 
IX 
There are many unknown factors that can be added to those men-
tioned above that probably can determine whether and where ca lc i -
f ications occur. 
1.4.3 Factors invoked in the origin of SPDC 
The question of which of the above mentioned factors are involved 
in the origin of SPP^ ia- f ot been studied in detai l . The early 
proximity of calcif icdtio ÌS to vascular walls led some investigators 
to the assumption that a oscu la r component plays an important 
role in the origin of SPDC (68, 86). Others (10, 16, 4 1 , 66) were 
impressed by frequently observed disturbances of the calcium-pl os-
phate metabolism in SPDC patients. These researchers suggested 
that local changes of calcium concentrations could alter vascular 
permeabil i ty resulting in the permeation of phosphate rich serum, 
which in turn could provoke calcium-phosphate deposits. 
1.5 Disorders associated with SPDC 
There are many di f ferent disorders associated with SPDC. Since 
the use of CT scanning the numbei of disorders associated with 
SPDC has increased. SPDC has not only been diagnosed in neurolo-
gical disorders, but abo in man ν other disorders, covering many 
fields of medicine. Conscqucntk, i t is impossible to produce a com­
plete l ist of disorders in which SPDC has been reported. 
A f t e r reviewing the l i terature on SPDC, we have subdivided the 
most frequently reported disorders associated with SPDC into three 
groups, according to the localization of the calcif icat ions. Each 
of these groups is subdivided into " fami l ia l " and "sporadic" disorders. 
The three groups include: 
a. Disorders associated with symmetrical calcif icat ions only in 
the basal ganglia (table 1). 
b. Disorders associated with symmetrical calcif icat ions only in the 
dentate nuclei (Table 2). 
с Disorders associated with calcif icat ions in both basal ganglia 
and dentate nuclei (Table 3). 19 
Autosonidl dominant: 
- dutosomal dominant icbonathic SFHC (5. 12. 8cí. 12'J. 
- autosomal dorTimait .diopathic hvpupartifh\rcidisrn (3). 
\utosomai rcccssise: 
- autosomal recess \o id.oputhic ^F1['ÌC (Ьі. 1?гі). 
- Cockavnc's ssndroi Ό i'-t?). 
Sporadic disorders 
- disturbed Ca-tJ metabolism: 
- h\Dopa'-ath\ro[dis M (-. ; | , 27, 2L). 31. 3f. ^C. ^6. 68, 77. 
101). 
- hvperpdrotinroidism (ЭІ). 
- intoxie ations: 
- post-rdd'díion-ru'rapv (6"·. ^6). 
- post-mctMûtrt'Vdte thcrjps (33. i ) . 76). 
- leukemia (lOf). 
- hvpoxaemu: 
- rerebro\dscu а-" dC4.ideiir-> (16. 61. S?'. \YJ). 
- ( arbon monoxide рсмьо. п^ (6, 60. 61, 6S). 
- infec tions: 
- гч^отера'оч irns (b, 63. 11b). 
-
 r
oxopldsmosis (6. 6S). 
- phacomatosis: 
- tuberous sclerosis (6, 68. 1C9). 
- Sturgc-\teber (6. 6S. M9). 
- others: 
- idiopatb'C SPDC (7. 2Z, 3?. 3S. Ï* 5, >9, 61. 6S, 7b. S2, І 0 \ 
I l i . I ' / ) . 
- mitochondrial oncepha'or i\opatnios: 
- Kojrnb-Sdjro (93. iG3). 
- uncldssified (70, 1071. 
- chromosomal abnormalnes : 
- Trisomy 21 (51, ^ . 79). 
Table I. 
Disorders associated with symmetrical calcifications found only in th< 
basal ganglia. 
Table 2. 
Disorders associated w i t h s y m m e t r i c a l c a l c i f i c a t i o n s (ound only in the 
d e n t a t e nucle i . 
Id iopathic SPDC (58, 62). 
Lead Poisoning (I 12). 
Table 2. 
Disorders associated w i t h symmetr ical calci f icat ions found only in the 
dentate nuclei . 
Tabic 3. 
Disoiders associated w j t h s>mmetrjcaJ c a l c i f i r a t i o n s in both basaJ ganglia 
and dentate nucle i . 
F a m i l i a l disorders: 
- autosomal dominant: 
- uuTosonidl dominant u' iopa'hif MMX (12. 120). 
- a u t o s o T i d ! dor mant ΐ ο ι ο ρ α ' Ί κ h s p o p a r a t h ^ -
ro id ism Í1 3). 
- auto^orra l recessive. 
- a u t o s o m a l recessive idiopathic SPHC (2, 9 ( 
9, 22, 37, 72, 73, SS, I 10, 12' ). 
- a u t o s o m a l recessive idiopathic M M X - " p l u s " 
(39, ùft. 7 3 . 113). 
- Cockavnc's svrdrotTie (^2. ^3. 108). 
Sporadic disorders: 
- idiopathic SPDC (28, 52, 57, 61, 68, 69, 87, 95, IG*, 117, 
119). 
- hypopara ihyro id ism (8, 35, 36, 50, 101). 
Table 3. 
Disorders associated w i th symmetr ical calci f icat ions in both basal ganglia 
and dentate nuclei. 
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Because CT scanning ensures a better localization of cerebral ca lc i -
i icat ions than plain skull radiograms, many patients now summarized 
in table I on account of their skull radiograms would be summarized 
in table 3 had CT scanning been perlormed. 
Famil ia l SPOC has been described as hawng either an autosomal 
dominant or an dutosomal recessive mode of inheritance (12, 68). 
The autosomal dominant inherited disorder is reported to be associated 
with autosomal dominant hyooparathyroidism (idiopathic hypopara­
thyroidism, pseudohvpoparath>roidism and pseudo-pseudohypopara-
th>roidism) (68, 83). Whether SPDC occurs in autosomal recessive 
or X-Unked h\poparath\ roidism is unknown because the incidence 
of MMX m tl ese l o r r i s ι» l a m i l j l hvooparathyroid sm ha^ not 
been reported a 1 lar is we r- ιο\, 
In man> ol the l i terature ecorded SPOC patients ι υ íViCJci(t could 
be found of a disturbed Ca Ρ metabolism, toxic and anoxic lactors, 
infections, phacomatosis, mi toe hondi ml disturbances, chromosomal 
abnormalities or Cockayne's syndrome. \X e have these patients 
classified as "idiopathic SPDC". According to Troost et al (113) 
the idiopathic SPDC patients desenbod bv Laubenthal (64) and Haller-
vorden (Ί6). Melchior (73), D'Hoore (28) and Troost (113) represent 
a separate ent i ty , as they show m addition to SPDC. psychomotor 
retardat ion, microcephaly, cerebral neuronal calc i f icat ion and hypo­
plasia of the cerebellum. Accordìi g to Goutieres (39) the idiopathic 
SPDC patients described bv Tervis (52), L\on (69), Goutieres (39), 
Hallervorden (^6) and Melchior (73) also represent a separate entity 
as they share SPDC, progressive encephalopathy, brain atrophy 
and leukodystrophy with persistent cerebrospinal f lu id lymphocytosis 
as characterist ic features. We have classified idiopathic SPDC patients 
belonging to the c n t m of Troost (113) and/or Goutieres (39) as 
idiopathic SPDC-"plus". The symptoms of the patients wi th autosomal 
recessive idiopathic SPDC "plus" (39, 46, 73, 113) are recorded 
in f ig . 1. The symptoms of the patients with autosomal recessive 
idiopathic SPDC and Cockavnc's syndrome wi l l be mentioned, res-
pectively, in chapters III and IV. 
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Mental retardation 
Hydrocephalus ^шт^тш^^^^шш^^^^^шш^^^шт^^т 
Microcephaly ^^^^Ш^ШШШШШШЯЕ^Ш^^^^^^^^Ш 
Myelinopathy ^Ш^^ЕШШ^^Ш^^^Ш^^^^ 
CSF Lymphocytosis ШІ^Ш^Ш^^^^Ш^^^^ЕШ^^ 
Impaired vision ^^ш^^т^ш^^^^^ш^^^^^^ 
Hypoplasia of cerebellum ^ м ^ ^ в м ^ ^ ^ н м а 
Striocerebellar signs ш^^ш^^^^^шяш 
Dwarfism ^ н ^ ^ ^ н и м н м і 
Seizures ^ ш н а ш ^ к ^ н ^ 
Deafness я м 
1
 ' ι ' ι ' ι ' ι ι I ' Ι ι I 
Number of patients 0 2 4 6 8 10 12 14 
^ и = Present 
Fig. 1 Symptoms in fourteen previously reported patients (39, 46, 73, 
113) with autosomal recessive idiopathic 5PDC-"plus". 
The obsenat ion thaï 70-80% oi the SPDC patients diagnosed on 
skull radiograms showed a disturbance in the calcium-phosphate 
metabolism suggested that a disturbed calcium-phosphate metabolism 
pla\s an impoi taut role in the origin ot bPDC (68, 72, 88). Sachs 
et al (101) tcuind that 930o ol the patients wi th known hypopara-
thyroidism showed CT sc an-diagnoscd SPDC. However, in only about 
10% of randomlv CT scan-diagnosed SPDC patients could a form 
of hypoparathyroidism be diagnosed (I 10). 
The presence o1 SPDC in the Kearns-Sayre syndrome (103) could 
be a consequence ot an unknown metabolic disorder which also 
produces the other signs ol this syndrome. The presence of Sr ,DC 
in the Kearns-Sayre syndrome could also be explained by the as-
sociation of hvpoparathyroidism ч ι th the Kearns-Sayre syndrome 
m, 94). 
PARATHYROID HORMONE AND ITS FUNCTION 
Parathyroid hormone 
Parathyroid hormone (PT4 N is a single chain polypeptide of 84 amino 
acids produced in the parathvroid gland (43). The PTH molecule 
is part ial ly broken down in the l i \ c r . bones and kidneys. Some of 
the PTH frag'TiCPis probably have biological act iv i ty (44). Serum 
PTH concentrations can be measured bv radio-immuno-assay (RIA) 
(18). However, the general inavailabil ity of homologous (i.e. human) 
PTH antiserum, the immunohetc rogemty of c irculat ing PTH and 
its fragments, in addition to the lack oi standardized reagent and 
assay procedures, ensure that interlaboratory assay results are diver­
gent and thus have to be i n t c p r e t e d very careful ly (18). 
Extracerebral effects of parathyroid hormone 
Studies on the fune tion of PTH have been performed mainly in 
extracerebral tissues where i t has been shown that PTH is the prin­
ciple regulator ol calcium concentration in extracellular f lu id ( I ) . 
Its mechanism of action is mainly mediated by its activating effect 
on the extracellular membrane-bound adenylcyclase complex: it acti­
vates the intracellular transformation of adenosine triphosphate 
into cyclic adenosine monophosphate (сЛМР), a second messenger, 
which stimulates specific properties of a cell (17, 23). 
In the renal proximal tubular cells, PTH stimulates the adenylcyclase 
system, resulting in a decrease of the renal threshold for phosphate 
(TmP/GFR, see reference I I ). A decrease in the extracellular phos­
phate concentration stimulates the hydroxylation of 25 OH cholecal-
ciferol into 1,25 (OH) 2 cholecalciferol in the interstitial renal cells. 
The hydroxylation might also be stimulated directly by PTH. 1,25 
(OH)
 ; cholecalciferol in turn stimulates the intestinal absorpt.on 
of calcium and increases serum calcium concentration. In the bones, 
PTH is involved in bone turnover by the stimulation of calcium 
mobilisation from the bone cells. This results in an increase in serum 
calcium concentration. An increase in calcium concentration decreases 
PTH secretion from the parathyroid gland (fig. 2) (1, 71). 
2.3 Cerebral effects of parath\roid hormone 
Many different neurological disturbances, including mental retardation, 
psychosis, pyramidal, extrapyramidal and cerebellar signs. EEG dis­
turbances and SPDC, are associated with hypoparathyroidism (36). 
Except for SPDC, these signs of cerebral dysfunction are also as­
sociated with hypoparathyroidism (36). This suggests that PTH influen­
ces cerebral function. It is probable that this influence is mainly 
indirect by affecting the Ca-P metabolism. For instance, the obser­
vation that seizures in parathyroid-ectomised patients are controlled 
by correction of the serum Ca levels by administering Ca (36) suggests 
that the seizures are the consequence of low serum Ca levels and 
not the consequence of low PTH levels. The additional observation 
that SPDC remains present in these patients suggests that other 
factors influence the presence of SPDC. 
As far as we know, a direct influence of PTH on cerebral function 
has not yet been demonstrated, neither has the presence of cerebral 
25 
PTH 
¡ renal adenylcyclase complex ¡ 
renal cAMP t >• TmP/GFR + • Ρ + 
(?) 
Ca mobilization from bones + 
25 OH cholecalciferol >- 1,25 (0Н)2 cholecalciferol 
intestinal Ca absorption + 
Fig. 2 Schematic representation of the influence of parathyroid hormone 
on the calcium-phosphate metabolism 
PTH receptors been shown. Recently, cerebral receptors oí 1,25 
(OH)2 rholecalciferol and calcitonin have been demonstrated (97, 
111). The effects of their stimulation are still unknown. 
OUTLINE OF THE STL DIES ON FAMILIAL STRIO-PALLIDO-DEN-
TATE CALCINOSIS 
I History 
The investigations on familial SPDC were performed after we had 
been confronted with a tamil} with autosomal dominant SPDC and 
two families with autosomal recessive SPDC. Reviewing the hterat ire, 
we concluded that the symptomatology and the etiology of SPDC 
were greatly unknown. 
The most recent extensive studies on SPDC had been published 
about 15 years ago (68). Since that time many new techniques (CT 
scanning, evoked potentials, histochermcal and electron microscopic 
techniques to studj rt iv · d •> nerve biopsies) have been developed 
to study neurological signs, rt e wond red if these techniques could 
help obtain more knov ledp' ..boi t the svmptomatclogy and etiology 
of SPDC. 
From the literature ο ι SPDC it wai e\ iden1 that тап\ exogenous 
and endogeno is factors arc unol xl m ' e orig'n of SPDC. The 
only known endogenous factor is a disiu'Dance somewhere in the 
calcium-phosphate metabolism. Endogenous factors play an important 
role in the etiology of familial disorders. In autosomal recessive 
disorders the endogenous factor is a defective enzyme produced 
by a gene defect. Thus it ma> be possible that autosomal recessive 
SPDC is associated with a defective enz> me by which a disturbance 
in the calcium-phosphate metabolism is produced. To test this hypo­
thesis we studied calcium-phosphate metabolism in our patients 
with autosomal recessive SPDC. 
Calcium-phosphate metabolism is grcatlv mf luenc ed b> parathyroid 
hormone. Because the parathyroid hormone seemed to influence 
cerebral functions we were cspeciall) interested in methods of 
2/ 
studying this influence. However, we were not able to study this 
influence of PTH on cerebral functions with conventional methods. 
In analogy with the PTH stimulated renal adeny Icyc lase complex, 
wc hypothesized the presence of a cerebral PTH-responsive adenyl-
cyclase complex. We tested this hypothesis in three healthy persons 
and studied the fune tion of this cerebral PTH-responsive adenylcy-
clase complex in a patient with autosomal recessive idiopathic SPDC 
and in a patient with Cockayne's s>ndrome. 
Aim of the investigations 
In our study we wanted to answer the following questions: 
a. Is familial SPDC characterized by a specific entity of neurological 
signs7 
b. Is a disturbance of the calcium-phosphate metabolism involved 
in the origin of autosomal recessive idiopathic SPDC and 
Cockayne's syndrome'' 
c. Can indications be found for the presence of a cerebral PTH-res-
ponsive adenylcyclase complex7 
d. Is the function of the cerebral PTH-responsive adenylc>clase 
complex disturbed in autosomal recessive idiopathic SPDC and 
Cockayne's syndrome0 
Performance of the investigations 
In order to answer the above formulated questions we studied the 
neurological signs found in the affected members of a family with 
autosomal dominant idiopathic hypoparathyroidism, a family with 
autosomal recessive idiopathic SPDC and a family with Cockayne's 
syndrome. The results of our observations are described in chapters 
II, III and IV. The presence of a cerebral PTH-responsive adenylcyclase 
complex was investigated in another study. The results are recorded 
in chapter V. Calcium-phosphate metabolism and the cerebral PTH-
responsive adenylcyclase complex were studied in patients with 
autosomal recessive idiopathic SPDC and in patients with Cockayne's 
Syndrome. The results of these studies are recorded in chapter 
VI. Chapter VII contains the conclusions of our investigations on 
some clinical and etiological aspects of familial SPDC. 
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CHAPTER II 
AUTOSOMAL DOMINANT IDIOPATHIC HYPOPARATHYROIDISM 
AND NERVOUS SYSTEM DYSFUNCTION: 
REPORT OF THREE CASES AND REVIEW OF THE LITERATI ЖЕ 
M. Smits, F. Gabreëls, P. Froeling, H. Thijssen, E. Colon, B. ter H.-tr 
С. Ruland, and R. ' t Lam 
3 Neurol (1982) 228: 113-122 
SUMMARY 
The neurological manifestations of idiopathic hypoparathyroidism in a 
father, his son, and his daughter are reported. In all three epilepsy was 
the f i rs t manifestation of the disease. Father and son also showed mental 
deteriorat ion and striocerebellar symptoms; their CT scans revealed symme-
t r ica l ca lc i f icat ion in the basal ganglia and dentate nuclei. The extent 
of this calc i f icat ion increased during normocalcemia, which was produced 
by dihydrotachysterol therapy. This indicates that other factors than merely 
hypocalcemia influence the intracerebral calc i fy ing process. 
Somatosensory evoked potentials (SSEP) showed an abnormal nonspecific 
complex, indicating dysfunction of the cor t ica l gray matter. 
I t is suggested that in the evaluation of idiopathic hypoparathyroidism 
one also must be beware of the possibility of epilepsy, mental deter iorat ion, 
striocerebellar symptoms, intracerebral ca lc i f icat ion and SSEP disturbances. 
u? 
INTRODUCTION 
Idiopathic hypoparathyroidism (IHPT) is a rare disorder characterized 
by hypocalcemia, hyperphosphatemia, and a low serum parathyroid hormone 
concentration, in the absence of renal impairment, malabsorption, osteo­
malacia, malignant disease, and a history of neck surgery or irradiation 
[15]. 
Neurological symptoms associated with IHPT are tetany, mental deteriora­
tion, epileptic seizures, signs of intracranial hypertension, pyramidal, 
extrapyramidal and cerebellar signs, psychosis, depression, calcification 
in the basal ganglia and dentate nuclei, and nonspecific disturbances in 
the electroencephalogram [10, 11, 12, 16, 17, 24, 25, 30, 32, 33, 37, >8]. 
Atypical myopathy has been reported in four sporadic cases of IHPT [31, 
42] and axonal neuropathy in one case [14]. 
Familial IHPT has an autosomal dominant, autosomal recessive or X-linked 
mode of inheritance [1, 2]. Until now only five families have ever been 
described with autosomal dominant IHPT [1, 5]. 
We report here the clinical, neuroradiological, and electroneurophysiological 
findings in three members of a family with autosomal dominant IHPT 
and the histopathological findings of sural nerve and soleus muscle biopsies 
in one member of this family. 
о <! !> с 
о — 
!> с 1 
ι—« 
Case 2 
I 1 ( > <! !> ¿ 
Case 1 Case 3 
О Normal. 
Ш Hypoparathyroidism; calcification in the basal ganglia and 
dentate nuclei. 
Φ Hypoparathyroidism; normal CT scan. Fig. 1. Pedigree of family 
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Fig. 2. CT scan of case I showing calcification in the dentate nuclei, 
vermis superior, basal ganglia, and cerebral white matter 
CASE REPORTS 
Famiiy study 
In ail members of the described nonconsanguincous family (Fig. I) general, 
physical, and neurological examinations were conducted. Serum calcium 
(Ca), phosphate (P), magnesium (Mg), parathyroid hormone (PTH), and 
calcitonin concentrations were measured and computed tomographic (CT) 
scanning was performed. 
Except for cases I, 2, and 3, all members had a normal history. Case 
2 stated that his only sibling and his sibling's children are healthy. The 
father and mother of case 2, deceased at the time of this study, had 
an apparently normal history. 
Uk 
Case 1 
From age 2 years onwards, case 1 had a history of generalized seizures, 
which could not be controlled by the usual anticonvulsant drugs. From 
age 15 he did not take any medication. There was alcohol abuse from 
age 14. 
At age 16 he was admitted, unconscious, to the Department of Internal 
Medicine. Chvostek and Trousseau signs were strongly positive. Serum 
Ca concentration was 1.10 mmol/1 (normal 2.20-2.60) and serum Ρ 1.62 
mmol/1 (normal 0.76-1.24). Serum PTH was undetectable by radioimmunoas­
say. Intravenously administered PTH resulted in a normal decline of the 
elevated renal threshold for Ρ (physiologically expressed as maximal tubular 
reabsorption correlated to the glomerular filtration rate, Tm/GFR). The 
serum Mg concentration was 0.49 mmol/1 (normal 0.80-1.00), serum gluta­
mic-oxaloacetic transaminase (SCOT) 62U/1 (normal 5-15), serum glutamic-
pyruvic transaminase (SGPT) 67U/1 (normal 5-15), and the gamma-glutamyl 
transpeptidase (gamma GT) 200U/1 (normal 6-36). Results of other relevant 
laborator> tests, including hematologic evaluation, renal, adrenal and 
pituitary function tests, calcitonin, alkaline phosphatase, lactate dehydro­
genase, and electrophoretic analysis of serum proteins were normal. There 
was no evidence of malabsorption. Intravenously administered Mg. did 
not influence the serum Cd and Ρ concentrations. 
Radiological examination of the hands and long bones did not reveal any 
abnormality; skull radiograms showed calcification in the basal ganglia 
and cerebellum. 
The diagnosis of IHPT was made and treatment with dihydrotachysterol 
was started. As a result, serum Ca concentration returned to a normal 
level, while serum Mg concentrations varied between 0.50 and 0.90 mmol/1. 
Epileptic seizures have not been observed since this treatment began. 
At age 25, suffering from headache, he came to the Department of Neuro­
logy. A general physical examination showed that heart and lungs were 
normal, the liver was palpable two fingers below the costal margin and 
Chvostek and Trousseau signs were negative. There was a slight cogwheel 
rigidity and a masklike face. His gait was ataxic and there was a slight 
dysmetna. Reflexes and sensibility were normal. Plantar reflexes were 
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flexor. Ophthalmological examination revealed no abnormality. 
Psychoíogicaí examination. Groninger Intelligence Test (GIT) 1Q: 94. The 
test profile was disharmonie (range 2Л sigma; normal 2.0). Estimated 
IQ according to school performance: 110. Trailmaking test: \U points 
(cutt-off point 13). Benton test: 5 items correct (expected score: 7 items). 
These test results are consistent with slight mental deterioration. 
The electroencephalogram (EEG) showed slowing of background activity 
with generalized regular theta paroxysms. The electromyograms and the 
conduction velocities of motor and sensory nerves were normal. There 
were no signs of latent tetany [36] within 3 mm of hypoxemia. Studies 
of somatosensory evoked potentials (SSEP), performed according to Colon 
et al. [7], showed an abnormal nonspecific complex [13], expressed by 
latencies P100, N'145 and P200 (Table 1). 
The skull radiograms showed a slight increase in intracerebral calcification. 
The CT scan revealed that this intracerebral calcification was localized 
in the basal ganglia, dentate nuclei, \ermis superior, and cerebral white 
matter (Fig. 2, Table 2). 
Surai nerve and soleus muscie biopsies. The light and electron microscopical 
examinations of the sural nerve, includ'ng teased fiber studies and histo-
metry, revealed slight signs of axonal neuropathy. The soleus muscle biopsy 
showed no marked abonormalities; but some mtrafascicular fat cells and 
a single angular atrophic muscle fiber were observed. 
Case 2 
Case 2, the father of case 1, was examined at age 51 years, just after 
the diagnosis of IHPT had been made in his son. At that time, studies 
of serum Ca, Ρ, Mg, PTH, and calcitonin revealed no abnormalities. He 
had normal health until age 56, when he was admitted to the Department 
of Internal Medicine after suffering a generalized seizure. Chvostek and 
Trousseau signs were positive. There was hypocalcemia (Ca: 1.60 mmol/1) 
and hyperphosphatemia (P: 1.39 mmol/1). PTH was undetectable. Intravenous-
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Fig. 3. CT scan oí case 2 showing calcification in the dentate nuclei 
and basal ganglia. 
ly administered parathyroid hormone provoked a normal decline of Tm/GFR. 
Serum concentrations of Mg and liver enzymes were normal, as were 
the results of the other laboratory tests performed as in case 1. Radiolo-
gical examination of hands, long bones, and skull did not reveal any abnor-
mal i ty. 
The diagnosis of IHPT was made and treatment wi th dthydrotachysterol 
was started. Subsequently, the Ca concentration returned to a normal 
level and seizures were no longer observed. 
A t age 59 years he was examined at the Department of Neurology. A 
general physical examination revealed no abnormalit ies. Chvostek and 
Trousseau signs were negative. Neurological examination revealed slight 
cogwheel r ig id i ty and a masklike face. His gait wat ataxic and there was 
a slight dysmctna. These striocerebellar symptoms were less pronounced 
than those found in his son (case 1). Sensation was normal. Plantar reflexes 
were f lexor. Ophthalmolgical examination revealed no abnormali ty. 
^7 
Table 1. Latencies of somatosensory evoked potentials (SSEP) in idiopathic 
hypoparathyroidism (IHPT) 
Latencies (ms) 
Specific complex Nonspecific complex 
N20 P45 PlOO N145 P200 
1 
2 
A 
В 
С 
Normal 
M 
M 
M 
M 
F 
values. 
25 
59 
40 
58 
27 
Mean 
SD 
9 
3 
20 
10 
9 
216 
21.5 
21.0 
25.6ς 
22 4 
19.2 
2.4 
44 8 
45.0 
42 0 
54.0'· 
36.0 
41.2 
4.5 
116e 
146-
268' 
106 
\52" 
96.5 
8.0 
160e 
258e 
380e 
236e 
200e 
126 
15.0 
280e 
350e 
b с 
Ь с 
il с 
203 
17.1 
* Cases 1 and 2 represent two patients described in the current paper. Cases A. B, and С arc three 
other patients with IHPT (spoiadic form) 
ь
 Peak could not be detected (latencv > 500 ms) 
c
 Latencies > mean + 2SD 
Psychological examination. GIT IQ: 103. The t e s t profi le was d isharmonie 
( range 2.8 s igma). E s t i m a t e d IQ according to school p e r f o r m a n c e : 115. 
Tra i lmaking t e s t : 7 points , üen ton t e s t : 2 i tems c o r r e c t . These t e s t resul ts 
a r e cons i s t en t with menta l de t e r io ra t i on . 
The EEG revea led no abnormal i t i e s . E l ec t romyograms and conduct ion 
ve loc i t ies of motor and sensory nerves were normal . There were no signs 
of l a t e n t t e t any within 3 mm of hypoxemia. SSEP s tudies showed an abnor-
mal nonspecif ic complex (Table I). 
Skull r ad iograms showed calc i f ica t ion in the basal ganglia and d e n t a t e 
nuclei (Fig. 3, Table 2). 
Case 3 
C a s e 3, a s is ter of c a se 1, was inves t iga ted a t age 15 years , when the 
diagnosis of IHPT was made in her b ro the r . Serum Ca , Ρ, Mg, PTH, and 
ca lc i tonin levels w e r e n o r m a l . She had a n o r m a l history until age 23, 
when she was a d m i t t e d to t h e D e p a r t m e n t of Internal Medicine a f t e r 
Case Se\ Age 
fvrs) 
Dura­
tion of 
clinical 
mani­
festation 
(vrs) 
üS 
Table 2. Localization of the intracerebral calcification in three cases 
with autosomal dominant idiopathic hypoparathyroidism (IHPT) 
Case 
1 
2 
3 
Duration of 
IHPT (>rs) 
11 
3 
0 
Calcification in 
Basal ganglia 
+ 
+ 
-
Dentate nuclei 
+ 
4-
-
Cerebral 
white 
matter 
+ 
-
-
suffering a generalized seizure. Except for positive Chvostek and Trousseau 
signs, the results of general physical, neurological and ophthalmological 
examinations were normal. Biochemical investigations revealed hypocalcemia 
(Ca: 1.80 mmol/1) and hyperphosphatemia (P: 1.60 mmol/1). 
Serum PTH was undetectable. Intravenously administered PTH provoked 
a normal decline of Tm/GFR. Results of the other laboratory tests per-
formed as in case 1 were normal. 
The diagnosis of IHPT was made and treatment with dihydrotachysterol 
was started. Subsequently, the Ca concentration returned to a normal 
level and seizures were no longer observed. 
Psychological and clinical neurophysiological examinations were not per-
formed. Radiograms of skull, hands and long bones, as well as CT scan, 
revealed no abnormalities. 
DISCUSSION 
The clinical and biochemical studies in these cases are consistent with 
IHPT. The pedigree (Fig. 1) strongly suggests autosomal dominant inheri-
tance. However, the disorder could be inherited as an autosomal recessive 
if the father (case 2) is homozygous and his wife heterozygous. Because 
of the chance of this combination is very remote in such a rare disorder, 
the autosomal dominant mode of inheritance is far more likely. 
Reviewing the literature, we found 23 cases (13 males, 10 females) in 
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Fig. 4 Neurological symptoms in 23 previously published cases and our 
3 presented cases with autosomal dominant idiopathic hypoparathyroidism 
5 famil ies where autosomal dominant IHPT is described [ I , 5, 20, 27]. 
The neurological symptoms mentioned are described in Fig. U. In many 
cases the f i rst cl in ical manifestation of IHPT was epilepsy, which was 
control led when normocalcemia was achieved. This i l lustrates that in 
patients with seizures of unknown etiology, hypocalcemia has to be con­
sidered. 
Cases 2 and 3, having shown normal serum Ca and Ρ levels, subsequently 
developed hypoparathyroidism a few years later. As fas as we know, such 
an occurrence has been reported only once in a case of fami l ia l idiopathic 
hypoparathyroidism [ 6 ] . 
Hypomagnesemia may be associated with hypoparathyroidism [28, 40]. 
However, the hypomagnesemia found in case 1 was probably due to alcohol 
abuse. In our opinion, the elevated SCOT, SGPT, and gamma GT concentra­
tions, the axonal neuropathy and the abnormal findings in the muscle 
biopsy were also a consequence of alcohol abuse. 
Detai led neuropathological studies of fami l ia l IHPT have not yet been 
reported. However, some sporadi1" cases have shown deposits of calcium 
and phosphate in and around the capillary walls of the basal ganglia, dentate 
nuclei, cort ica l layers, and in the cerebral and cerebellar white matter 
[8, 21 |. In vivo, this intracerebral ca lc i f icat ion can be diagnosed bv plain 
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skull radiograms. The incidence in IHPT is not known. In 50 cases of IHPT 
or surgically induced hypoparathyroidism, calcification in the basal ganglia 
detected by plain skull radiograms was found in 28% [A]. Because the 
CT scan is much more sensitive in detecting intracerebral calcification 
than plain skull radiograms [291, the incidence may prove to be higher. 
Until now, detailed CT scan studies have been reported in only three 
sporadic cases of IHPT. In two cases calcification was observed in the 
basal ganglia and in the cerebral white matter [22, 42]; in the third case 
the dentate nuclei were also involved [9]. 
Calcification in the basal ganglia only has been related to many disorders 
caused by exogenous or endogenous (familial or nonfamihal) factors [23, 
Ή ] . Calcification in the striopallidodentate system has, however, only 
been reported in cases of hypoparathyroidism [9, 23], idiopathic striopal­
lidodentate calcinosis [3, 23, 35], and Cockayne's syndrome [34, 39]. 
The lack of correlation between the relatively minor clinical symptomato­
logy and the extent of the basal ganglia calcification, which we have 
found in our investigations, has been observed frequently in cases where 
the basal ganglia calcification v^as detected bv CT scan [19, 41]. This 
could be explained by the results of neuropathological studies, showing 
that in the calcified areas the nerve cells remain intact for a long time 
[8, 26]. 
In cases 1 and 2, the skull radiograms showed an increase in intracerebral 
calcification. Varying +he kilovoltages used for skull radiography also 
varies the extent of the revealed calcification. This could therefore be 
the cause of the increase. However, in the cases described above the 
quality of the skull radiograms did not vary significantly. The increase in 
intracerebral calcification, observed while serum calcium was normal 
owing to dihydrotachysterol therapy, suggests that there are more factors 
influencing the calcifying process than merely hypocalcemia. This theory 
is also supported by the presence of normocalcemia in idiopathic strio­
pallidodentate calcinosis [3, 23, 35] and in Cockayne's syndrome [18, 34]. 
Table 2 suggests an increase in intracerebral calcification with the duration 
of IHPT. However, like many other autosomal dominant inherited disorders, 
IHPT may have a variable expression, which could also explain the dif­
ference in extent. The observation that the dentate nuclei calcification 
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in case 1 was less pronounced than those in case 2 (Figs. 2 and 3) indicates 
that still more factors influence the calcifying process. 
The SSEP studies conducted in cases 1 and 2 (Table 1) show a normal 
specific complex, which reflects the spinothalamocortical projection, 
indicating a normal function of the white matter. The nonspecific complex, 
which is a reflection on the diffuse spread of sensory information over 
the cortex, was abnormal. This indicates dysfunction of the cortical gray 
matter [7, 131. 
Because SSEP studies in IHPT have not yet been reported, we studied 
consecutively three patients with sporadic IHPT (Table 1). They showed 
mental deterioration, striocerebellar symptoms and calcification in the 
striopallidodentate system. In one of them (case B, Table 1) polyneuropathy 
was also present. The delayed latencies of the specific complex of the 
SSEP (Table 1) probably are a consequence of this. In all cases with IHPT 
the SSEP studies indicated gray matter dysfunction. This finding correlates 
positively with the psychological test results, which showed mental de­
terioration. 
The results of our shbd c«; inri с ate tl,dt ,ΡΤ is also manifested by dys­
function of the cerebral roriical layes . Dasal ganglia and dentate nuclei. 
It is still unknown whether tetanv is a consequence of peripheral or central 
nervous b>siem disorder Ll2j. 
Further studies are required in order to assess the ^elative importance 
of epilepsy, menta! deterioration, striocerebellar symptoms, intracerebral 
calcifications, and S^EP disturbances in the evaluation of familial and 
sporadic cases of IHPT. 
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CHAPTER IH 
PROGRESSIVE IDIOPATHIC STRIO-PALLIDO-DENTATE CALCINOSIS 
(FAHR'S DISEASE) WITH AUTOSOMAL RECESSIVE INHERITANCE 
Report of Three Siblings 
M. Smits, F. Cabreéis, H. Thijssen, H. ' t Lam, S. Notermans 
В. ter Haar, Л. Prick 
Eur. Neurol. (1982) 22: 58-6ÍÍ 
ABSTRACT 
3 siblings wi th symmetr icdl calci f icat ions in the str io-palhdo-dentate 
system are described. Parathyroid function was normal and there were 
no signs of central or peripheral myelinopathy. This is the 9th fami ly 
reported wi th autosomal recessive idiopathic str io-palhdo-dentate calcinosis 
and the f i rs t to be investigated by computerized tomography (CT). CT 
scans appeared to be superior to plain skull radiograms to assess the loca-
l izat ion and the extent of the calc i f icat ion in vivo. The calcif icat ions 
were the least extensive in the youngest and the most extensive in the 
eldest. I t is suggested that the calci fying process is a progressive disorder. 
It seems to start in the dentate nuclei and pons, and subsequently extends 
to the basal ganglia and to the radiation of the corpus callosum. 
¿«О 
INTRODUCTION 
Symmetrical calcifications in the stno-pallido-dentate system have been 
referred to as Fahr's disease, cerebral calcinosis and stno-pallido-dentate 
calcinosis (SPDC) [12]. Most patients with SPDC show progressive mental 
deterioration, and pyramidal, extrapyramidal and cerebellar signs [12]. 
Familial SPDC has been described with either an autosomal dominant 
or an autosomal recessne mode of inheritance [4, 12]. The autosomal 
dominant inherited disorder is reported to be associated with 
hypoparathyroidism and pseudohypoparathyroidism [12]. However, 6 families 
with autosomal dominant SPDC without endocrinologie or somatic abnor-
malities have been described [k]. The autosomal recessive inherited disorder 
is associated with Cockayne's syndrome, which is characterized by somatic 
abnormalities (dwarsfism, senile appearance, hypersensitive dermatitis, 
retinitis pigmentosa) as well as by neurologic disturbances (progressive 
SPDC, central and peripheral myelinopathy) [21]. 8 families with autosomal 
recessive SPDC without endocrinologie or somatic abnormalities have 
been recorded [1, 6-8, 13, 1^, 16, 22]. In all reported cases, the diagnosis 
was made by plain skull radiograms; in some cases it was also confirmed 
by neuropathologic studies [1, 3, 6, 1^]. 
Lsing computerized tomography (CT), it is possible to locate and estimate 
the volume of the intracerebral calcifications more exactly than with 
plain skull radiograms [10]. 
\X e report here the results of clinical, neuroradiologic and electroneuro-
phvsiologic investigations m 3 siblings with SPDC and describe the findings 
of nerve and muscle biopsies in 1 sibling. 
CASE REPORT 
The genealogie tree of the non-consanguineous family (fig. 1) suggests 
an autosomal recessive mode of inheritance. 
Case 1 
This ^ 1-year-old ex-nurse was seen in our department because of progres-
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sive impairment in speech and motor abi l i ty , which had originated about 
4 years before. Appearance, height and the results of medical examination 
were normal. There were no deformit ies of hands, feet , skin or nails. 
Enamel and tooth development were normal. 
Neurologic examination revealed choreic movements of head, tongue and 
limbs. There was a moderate dysarthria. The gait was ataxic and there 
was a slight dysmetna. The myotatic reflexes were normal, while plantar 
reflexes were f lexor. Sensitivity was normal. The ophthalmologic exami-
nation showed no disturbances. 
Psychological examination: general intell igence ^ AIS fu l l scale IQ: 95 
(verbal IQ: 107; performance IQ: 82). Wechsler memory scale: MQ: 96. 
About 18 months later WAIS fu l l scale IQ was 87 (verbal IQ: 97; perfor-
mance IQ: 76). Trai l -making test: 2 points on A and В (cut off point: 
12). Benton test: 3 items correct (expected score: 8 items). These test 
results strongly suggest mental deteriorat ion. 
Laboratory tests, including hematologic evaluation, hepatic, renal, adrenal, 
thyroid and pituitary funct ion tests and electrophoretic analysis of serum 
proteins were normal. Appropriate studies excluded mercury and lead 
intoxications, deficiencies of thiamine, pyridoxine, cobalamine, folate 
and ascorbate,and tuberculosis, toxoplasmosis or syphilis. Other tests 
giving normal results included those for serum lipids, amino acids in plasma 
and urine, plasma shortchain f a t t y acids and organic acids, lysosomal 
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enzymes, ceruloplasmine, lactate, pyruvate and oral glucose tolerance. 
Serum calcium, phosphorus, magnesium, zinc, calcitonin, parathormone 
and 2it-hour urinary calcium, phosphorus and magnesium excretion were 
normal. Intravenous injection oí 200 USP units parathormone (Eli Lilly) 
gave a normal increase of urinary phosphorus and 3 ':5 -AMP excretion. 
Cerebrospinal fluid studies included those for cell count, protein content, 
protein and Immunoelectrophoresis, chloride, sodium, potassium, calcium, 
phosphorus, magnesium, zinc, copper, glucose, lactate, pyruvate, aspartate 
transaminase, lactate dehydrogenase and creatine Phosphokinase; the results 
ot these studies were normal. Cerebrospinal fluid amino acids (including 
glutamic acid, glycine and γ -aminobutyric acid), homovanilhc acid and 
5-hydroxyindole acetic acid were also normal. 
Audiograms, electrocardiogram, karyogram and radiograms of hands, feet 
and long bones were normal. 
Case 2 and 3 
Case 2, a 36-year-old male, and case 3, a 32-year-old male, had normal 
histories. General and neurologic examination were normal. Results from 
the same laboratory tests as performed in case 1 showed no abnormalities. 
INVESTIGATION OF THE NERVOUS SYSTEM 
Central Nervous System 
Neuroradiology. In case 1, radiograms of the skull showed dense symmetri­
cal calcifications in the area of the basal ganglia and dentate nuclei. 
The CT scan of case 1 revealed extensive symmetrical calcifications 
in the striatum, globus pallidus, dentate nucleus, pons and in the radiation 
of the corpus callosum. In cases 2 and 3, the radiograms of the skull 
were normal. However, the CT scans revealed that in case 2 there were 
extensive symmetrical calcifications in the dentate nuclei and moderate 
symmetrical calcifications in all other areas mentioned in case 1. In case 
3, the calcifications, visible on the CT scans, were restricted to the dentate 
nucleus and pons (fig. 2). 
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Electroencephalography and Evoked Potentials. 
The electroencephalograms oí the 3 siblings were similar: bram stem dys-
function was indicated vuth ¿ projection in both temporal regions. Somato-
sensitive, visual and brain stem auditory evoked potentials were normal. 
Peripheral Nervous System 
Electroneurographic Measurements. E l e c t r o m y o g r a m s and conduction 
velocities of motor and sensory nerves were normal in the 3 siblings. 
Sura! Nerve and Soîeus Muscle Biopsies. In case 1, light- and electron-
microscopic examinations, including teased fiber studies and histometry, 
revealed no abnormalities in particular, no signs of segmental de- and 
remyehnation were observed. 
DISCUSSION 
The eldest sibling suffered from a progressive disorder manifested by 
mental deterioration, st' lO-t =rebellar symptoms and calcifications in the 
strio-palhdo-dentate syst^^1 pons and radiation of the corpus callosum. 
In the 2 younger siblin^c the cale if ¡cations were less extensive, and, 
at the time of this S^JC'', no neurological disturbances were detected. 
Metabolic disorders, especially parathyroid dysfunction, have been excluded 
in all 3 cases. There were no signs of the somatic abnormalities and the 
peripheral and central myelinopathy associated with Cockayne's syndrome 
[21]. 
Reviewing the literature, we found 25 cases of autosomal recessive idio-
pathic SPDC in 8 families (table I). The age at onset of symptoms was 
recorded in 23 cases: in ч cases from 3 families [1, 8, 1^ 1 the symptoms 
appeared before age 10, in 12 cases from 4 other families [6, 13, 16, 
22J the symptoms became manifest at middle age (fig. 3). This suggests 
there is an infantile and an adult form of the disorder. 
Detailed neuropathologic tudies on some of the cases [3, 6, 1^ ] revealed 
extensive symmetrical pericaoillary calcifications in the putamen, caudate 
nucleus, globus pallidus, d^n a te nucleus, brain stem and in the cerebral 
Fig. 2. CT scan of 3 siblings w i t h autosomal recessive idiopathic str io-
pall ido-dentate calcinosis. With increasing age, more symmetr ical c a l c i f i ­
cations are visible in the s t r i a t u m , globus pallidus, dentate nucleus, pons 
and radiation of the corpus callosorum. a-c Case 3 (age 32 years), d-f 
Case 2 (age 36 years), g-i Case 1 (age Ή years). 
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F ig . 3. Age a t onset of symptoms 
in 23 patients wi th autosomal reces-
sive idiopathic str io-pal l ido-dentate 
calcinosis. 
and cerebellar white matter. The origin of the calcificatiorus is not known. 
Afa/thews [13 land \'y/and and Skre \ 16] found in their cases a subnormal 
phosphorus diuresis after exogenouslv administered parathormone, suggest-
ing an unusual type of pseudohypoparathyroidism. We could not conf i rm 
these findings in the present stud). 
Although CT scans are much more sensitive than plain skuil radiograms 
in detecting intracerebral calci f icat ions [101, SPDC is rarely observed 
in vivo. In studies involving a total of 26,100 CT scans Í5, 10, 15, 20], 
the occurence of lymmetr ica l cale if ications in the basal ganglia was deter-
mined. In 123 of these scans (0,5οό), symmetrical calcif ications in the 
basal ganglia were found and in 13 scans (0.05%) there were also sym­
metr ical calci f icat ions in the dentate muclei. These reports did not give 
enough relevant c l in ical information to determinate the presence of endo­
crinologie or somatic disturbances. In addition to the above studies, there 
are reports of 5 sporadic cases of hypoparathyroidism with SPDC, visible 
on CT scan [2, 7, 18], and 5 sporadic cases of SPDC without endocrinologie 
or somatic disturbances [9, 11]. 
In the siblings investigated here, the increase in the calcif ications wi th 
the age of the patients suggests a progressive calci fy ing process, which 
probably begins in the dentate nuclei and pons, and subsequently occurs 
in the basal ganglia and in the radiation of the corpus callosum. 
Because (pseudo)hypoparathyroidism is the only known metabolic disorder 
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Table î . Summary of findings in 8 previously published families and our 
presented family with autosomal recessive idiopathic strio-pallido-dentate 
calrmosis. 
Reference No This 
study 
Number of affected siblings 
Mental deterioration 
Ps>chosis and or depression 
Dysarthria 
Epileptic seizures 
Pyramidal signs 
Extrapyramidal signs 
Ataxia 
Disturbed EEG 
Calcifications in basal ganglia 
Calcifications in dentate nuclei 
Calcifications in white matter 
Central atrophy 
Autopsy examination 
Miscellaneous 
[8] 
3 
+ 
0 
+ 
+ 
+ 
+ 
+ 
о 
+ 
+ 
+ 
0 
+ ' 
[22] 
3 
о 
о 
+ 
0 
+ 
+ 
+ 
-
+ 
+ 
-Ι­
Ο 
-
ψ 
ИЗ] 
3 
+ 
0 
+ 
-
-
+ 
+ 
0 
+ 
+ 
0 
0 
-
ω 
[14] 
3 
-τ 
0 
+ 
-
+ 
+ 
0 
ο 
+ 
+ 
+ 
0 
+ 
ψ 
[6] 
3 
+ 
+ 
+ 
ο 
+ 
ο 
ο 
+ 
+ 
+ 
+ 
+ 
+ 
[1] 
3 
+ 
0 
0 
+ 
0 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
ψ 
[7] 
2 
+ 
0 
-
-
+ 
+ 
0 
+ 
+ 
+ 
+ 
0 
-
[16] 
5 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
ω 
3 
+ 
-
+ 
-
-
+ 
+ 
+ 
+ 
+ 
+ 
-
-
+ = Present, — = absent, о = not reported, ψ = retinitis pigmentosa, ω = atypical pseudohypoparathyroidism. 
Reported by Benne [3] 
associated with SPDC, it has been suggested that idiopathic SPDC could 
be a consequence of a disorder in the parathormone-regulated calcium 
metabolism [13, 16, 191. As autosomal recessive inheritance is usually 
associated with an enzyme deficiency, an enzyme deficiency somewhere 
ID the parathormone regulated calcium metabolism may play an important 
role in the mamiestation of idiopathic SPDC. Further investigations are 
necessary to confirm this theory. 
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CHAPTER IV 
PERIPHERAL AND CENTRAL MYELINOPATHY 
IN COCKAYNE'S SYNDROME. 
REPORT OF 3 SIBLINGS 
M. Smits, F. Cabreéis, VI. Renier, E. Joosten, Α. Gabreels-Festen, 
Η. ter Laak, A. Pinckers, G. Hombergen, S. Notermans, H. Thijssen 
Neuropediatrics (1982) 13: 161-167. 
ABSTRACT 
Three siblings with Cockayne's syndrome are reported. Sural nerve biopsies 
revealed segmental de- and remyelmation wi th omon-bulb format ion. 
Disturbed visual and brain-stem auditory evoked responses indicated demye-
lination of the central nervous system. The peripheral and central myelino-
pathy increased wi th age, suggesting a progressive disorder. Our observations 
support the theory of Cockayne' s syndrome being a leukodystrophy. 
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INTRODUCTION 
In 1936 Cockayne described 2 siblings who, after apparently normal early 
development, manifested dwarsfism, microcephaly, mental retardation, 
senile appearance, photosensitive dermatitis, retinal pigmentation, optic 
atrophy, cataract , prognathism and partial deafness. In 19^6 he reported 
on the progressive character of the disease.About 90 cases have subsequently 
been noted and many new features have been included in Cockayne' s syn­
drome (CS): disproportionately long extremities, carious teeth, thickened 
skull bones, calcifications of the basal ganglia, normal pressure hydroce­
phalus, peripheral neuropathy and extrapyramidal, pyramidal and cerebellar 
signs ( Gazzetta 1972, Jin et al 1979, Sof/er et al 1979). Almost none of the 
reported cases showed all these symptoms and laboratory investigations 
have not revealed any consistent abnormalities. The occurence of CS 
in siblings suggested autosomal recessive inheritance. The most constant 
neuropathologic findings have been white matter atrophy with patchy 
demyelination and calcifications of the basal ganglia ( Aioossy 1967, Crome 
and Kanjilal 1971, Soffer et al 1979). 
We report here the results of clinical, electroneurographic and neuroradio-
logic investigations in 3 siblings with CS and describe the histopathologic 
findings in nerve and muscle biopsies. 
О 
ni 1 1 i A 
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Fig. 1 The pedigree of the cases 
case case case 
1 2 3 of Cockayne's syndrome 
CASE REPORTS 
Case 1 
This 19-year-old male was investigated because of dwarsfism and a regres­
sion in psychomotor development. His parents are healthy and unrelated. 
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Except for his brother (ca^e 2) and sister (case 3), there іь no history 
of sirnilarlv af fected > hildren in the lami lv . 
With the exception ol a photosensitive dc-i mat ins, l o t e d at the age of 
6 months, his pt enata!, r v t a l and postnatal histories were unremarkable 
unt i l age 3. From that l ime and mcrcas'ng vwth age, dysarthria, tremors 
and a spast ic-atact ir syndrome developed. From age 10 a decrease in 
intell igence vvas noted. At age 12 routine laborator> investigations, elec­
troencephalogram and skull radiograms were all normal, but by age 17 skull 
radiograms indicated calcihcat ions m the area of the basal ganglia. From 
that age onwards he suffered relapsing psychotic periods, which could 
however be control led with neuroleptic therapy. 
At age 19 he was seen at our depaitment. On physical examination, he 
was small and thin wi th an old looking "bird headed dwarf" appearance, 
prognathism, loss of facial subcutaneous fat and heav\ Cvcbrow ridges. 
His teeth were very carious. His height was 135 cm P2.5), his weight 
33,и ' g ( P2.5) and the head circumference was 51.5 cm (P5). Lungs and 
heart were normal. The liver was palpable tv о fingers below the costal 
margin. The spleen was not palpe11)le. The genitals were normal. He had 
a marked kyphoscoliosis. There was a considerable dysarthria. A coarse 
postural tremor oí both hand^ and head, always present, increased with 
intentional movement.Further neurologic examination revealed a bi lateral 
spastic-atactic syndrome with atroph) and л с kr- ^ of the distal muscles. 
The myotat ic reflexes weie low, while p1.1! 1 » f l e x e s were extensor. 
Sensibility was normal. Psychological eva j ι i n re с ì led mental retarda-
tion (IQ 77). Dermatologie investigation confirmed that the skin was very 
sensitive to ul t raviolet l ight. Visual acuity for both eyes was 0.8. There 
was a slight nuclear punctate cataract. The fundus aspect was normal. 
The audiograms showed considerable perceptive high tone losses (65 dB 
at 4000 Hz). Normal relevant laboratory tests included renal, adrenal, 
thyroid and pi tu i tary function tests, cale mm, phosphorus, calci tonin, 
parathormone, copper, ceruloplasmin, lysosomal enzymes, aminoacids 
in plasma and urine, chromosomal studies and electrocardiogram. Serum 
glutamic oxalate transferase (SCOT; N 5-15 U/l), serum glutamic pvr jvate 
transaminase (SGPT; N 5-15 U/l) and γ glutamyl transpeptidase (У ОТ; 
7 Í | 
Ν 6-36 L/l) ^еге slightly higher thdn normal: 40, 25 and 131 U/l respective­
ly. The cerebrospinal fluid was normal except for an increased protein 
concentration (775 mg/1). Liver biopsy was normal. 
Case 2 
This 16-year-old male had the same history of intellectual deterioration 
dysarthria, photosensitive dermatitis, tremors and spastic-atactic syndrome 
as his affected brother. On physical examination, he had the same old 
looking appearance. His height was 137 cm i ' P2.5), his weight 37 kg ( < 
P2.5) and the head circumference was 52.5 cm (P25). Heart, lungs, abdomen 
and genitalia were normal. His skin was very sensitive to ultraviolet light. 
The dysarthria, tremors and spastic-atactic syndrome were less pronounced 
relative to those found in his elder brother. IQ was 74. Visual acuity for 
both eyes was 0.5. There was a slight nuclear punctate cataract . The 
fundus aspect was normal. The audiograms showed moderate perceptive 
high tone losses (40 dB at 4000 Hz). Laboratory test results were normal 
except for slightly ele\ated SCOT. SGPT and Ύ GT: 37, 131 and 48 U/l 
respectnely. 
Case 3 
This 13-year-old female аіьо had a history of tremors, dysarthria, intellec­
tual deterioration and spastic-atactic syndrome. Upon physical examination, 
she had the same old looking face but no loss of subcutaneous fat. Her 
height was 129 cm (''P2.5), her weight 30.5 kg (P5) and the head circum­
ference was 50.5 cm (PIO). Heart, lungs and abdomen were normal. Her 
skin was very sensitive to ultraviolet light. Compared with her affected 
brothers, the temors and spastic-atactic syndtome were the least pro­
nounced. IQ was 75. Visual acuity for both eyes was 0.7. There was a 
slight nuclear punctate cataract . The fundus aspect was normal. The audio­
grams were within normality. Results from laboratory investigations were 
normal except for slightly elevated SCOT, SGPT and ï GT: 33, 90 and 
40 U/l respectively. 
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INVESTIGATIONS OF THE CENTRAL NERVOUS SYSTEM 
Neuroradioiogy 
In case 1, radiograms showed that calcifications increased between ages 
17 and 19. In case 2 and 3, skull radiograms were normal. Computed tomo­
graphy (CT) scanning showed symmetrical calcifications m the basal ganglia 
and dentate nuclei in all 3 siblings. This occurred most extensively in 
case 1 and least extensively in case 3. The ventricles were enlarged. 
The ventriculocramal index (Hahn and Rim 1976) was ОЛЬ in case 1, 
OAb in case 2, and 0.37 in case 3 (normal value _+ SD: 0.31 _- 0.04). 
Eleclroneurophysiology 
The electroencephalograms of the 3 siblings were not essentially different, 
showing a little slowing of basal activity. 
Brainstem auditory evoked response (BAER) 
The results of brainstem evoked response audiometry are summarized 
in Table 1. In case 1, peak I and III could not be detected. Except for 
the I-III interpeak latency in case 3. all latencies were delayed significantly 
(P 0.0 5), being the most pronounced in the eldest, and the least pronounced 
in the youngest patient. 
Table I Interpeak latencies in brainstem auditory evoked responses in 
3 siblings with Cockayne's syndrome 
ІЩегр з к l a t e n c y I III III V 0 V 
Case Age Latency Normal val jes abs % Lalency Normal values abs % Latency Normal values abs % 
(yi) Ims'· Mean SO Mean SD Mean SO 
1 19 644 5 2 ; 016 1 73 33 
2 16 2 4 3 2 0 3 0 1 6 0 40 20 2 88 1 7 6 0 1 9 1 1 2 64 6 67 5 2 1 - 0 1 6 1 4 6 28 
3 13 1 98 1 9 3 0 14 0 05 3 2 52 1 6 5 0 1 9 0 90 56 5 77 4 9 4 - 0 8 3 0 6 3 17 
л
 abs absolute d Iference between patient and normal values to be interpreted as absolute nerve conduct on delay 
л
 % abs expressed in percentage 
0 stimulus onset 
nol detectable 
Normal values according to Debruyne eta1 (19 0) 
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Neuro-ophthalmologic examination 
Visual evoked cortical potentials (VECP) were recorded in the usual way. 
A ilashed-pattern-evoked-response was present in cases 2 and 3, but absent 
in case 1. A pattern-reversal-evoked response was present in case 3, but 
absent m case 1 and 2. 
Color vision was examined following the procedure described by Pinchers 
(1980). The results are listed in Table II. In case 1, the pseudo-isochromatic 
color (PIC) tests indicated a super-mild tot mild red-green defect. Red-
green defects were present in the Panel D 8/2. The FM 100 Hue error 
score was high. There was a neutral zone at yellow, red and red-purple 
with the New Color Test Box 6/4 (NCT 6/4). In cases 2 and 3, the PIC, 
NTC 6/4 and Panel D 8/2 test results were normal. The FM 100 Hue error 
score progressively increased from case 3 to case 1. 
Table II Color vision - as described by Pinckers (1980) - in 3 siblings with 
Cockayne's syndrome 
Case Age 
(yrl 
1 19 
2 16 
3 13 
codification 
Eye 
RE 
LE 
RE 
LE 
RE 
LE 
accord 
PIC tests 
TMC 
screening 
defect 
screening 
defect 
N 
N 
N 
N 
mg to François 
AOH-R-R 
screening 
RG-defect 
mild 
screening 
RG-delect 
: 
-
Ishihara 
'prtoi scorei 
6 
5 
0 
0 
2 
2 
and yemes! 11957) N 
FM 100 Hue Derivatives 
NCT 6/4 Panel D 8/2 
1//T+ 1//P 
1//PD 
1//DT 
neutral 2//P 
zone 2//T 
YR RP 
Э//Т+ 2 ME 
1//T 1//DT 
1//T+ 
N MET 
N 1//P 
1//T+ 
normal - not examined 
FM 100 Hue 
(error score) 
282 
261 
241 
172 
189 
169 
Anomaloscope 
Nagel Model II 
[Rayieigh equation} 
not perlormable 
1 00 
1 06 
106 
0 96 
1 00 
INVESTIGATIONS OF THE PERIPHERAL NERVOUS SYSTEM 
Eiectroneurographic measurements 
The nerve conduction volocities were decreased: the eldest patient showed 
the most pronounced decrease, the youngest patient the least (Table III). 
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Fig. 2 Sural nerve biopsies. The density of myelinated fibers is diminished 
in case 1 and 2. Slight onion-bulb format ion (S) is evident in case I , and 
is also sl ightly apparent in case 2. Few clusters of small f ibers (C) are 
seen in case 1 and 2. In case 3 there is an obvious lack of large diameter 
in f ibers. Epon I urn 850 χ 
SuraÍ nerve biopsies 
The sural nerve of case 1 showed the most extensive abnormalit ies. The 
density of myelinated fibers was moderately diminished, as was the total 
number of myelinated fibers (Figs. 2 and Table IV). The relat ive incidence 
of large fibers (more than 10 u m) vas diminished compared with age 
matched controls (Fig. 3). There was evidence of chronic segmental and 
paranodal demyelination and remyelination (Table IV) wi th onion-bulb 
format ion (Figs. 2 and 4). Secondary myelin breakdown (axonal degeneration) 
was observed sporadically. There were only a few clusters of small mey-
linated f ibers, indicating regeneration after axonal degeneration. Deposits 
of calcium could not be demonstated. 
In case 2, the density of mylmated fibers was low-normal. A normal total 
number of myelinated fibers was encountered (Table IV). Signs of segmental 
and paranodal de- and remyelination wi th slight onion-bulb format ion 
were present but were less pronounced than m case 1. Axonal degeneration 
was rarely observed and clusters were not seen. 
In case 3, the density and tota l number of myelinated fibers were normal 
(Table IV). The relat ive incidence of large fibers (more than 10 J m) was 
somewhat diminished (Fig. 3). The teased fiber preparations snowed some 
segmental de- and remyelinat ion. Onion-bulbs, however, were not observed. 
There was no axonal degeneration, nor cluster format ion. 
Muscie biopsies 
The biopsy of the soleus muscle of case 1 indicated the presence of severe 
abnormalit ies. Roth, fascicles consisting of normal sized type I fibers 
Table III Electroneurographic examination in 3 siblings with Cockayne's 
syndrome 
Case 1 Case 2 Casp 3 Normal values 
I19yr| (16yr) <13yr] Mean SD 
Motor nerve conduction velocities (m/sl 
lateral popliteal nerve 
tibial posterior nerve 
median nerve 
Sensory nerve conduction velocity (m/sl 
sural nervo 
- no response obtainable from denervated extensor digitorum brevis muscle 
/4 
31 32 50 7 5 
Э0 31 38 48 4 0 
34 39 40 57 5 6 
3' 39 44 45 3 4 
Table IV Density of myelinated fibers and condition of teased myelinated 
fibers in the sural nerve of 3 siblings with Cockayne's syndrome 
Case Age Density TTFA Type of myelinated libers (%)" 
(yr) (No/mm2) (mm2) А С D E F 
1 19 5500 13 43 27 6 0 24 
2 16 7100 11 71 5 2 2 20 
3 13 4200 0β 80 0 3 0 17 
Density mean controls + SD (η = 14 age 11 -30 уг) 10350 3200 
TTFA (total transverse fascicular area) mean controls 0 35тгтГ range 0 4 - 1 3 
' Capitals refer lo condition ol the teased libers (criteria according to Stevens et al 1973) 
A = normal appearance С = paranodal demyelination D = segmental demyelmation E = axonal degeneration with linear rows of myelin 
balls F = paranodal or segmental remyelmaticn 
and fascicles w i t h atrophic f ibers surrounded by many f a t cells, could 
be seen. Many muscle f ibers in the biopsy consisted of packed nuclei 
surrounded by the sarcolemma. In some fascicles about half of f ibers 
showed a target or targetoid-l ike appearance The terminal innervation 
rat io (TIR), measured according to Coë'rs et al (1973), was greatly increased: 
5.6 (N < 1.1), indicating a severe loss of motor axons. This loss was compen-
sated by the sprouting of the remaining axons. 
The biopsy of the soleus muscle of case 2 showed less marked disturbances, 
wi th only some atrophic and hypertrophic f ibers. The checkerboard-pattern 
of type I and type II f ibers was disturbed. The TIR was slightly increased 
(1.3). 
The biopsy of the soleus muscle of case 3 showed normal sized muscle 
f ibers, although the checkerboard-pattern was slightly disturbed. 
DISCUSSION 
Reviewing the l i terature concerning Cockayne's syndrome, we found 96 
cases in 66 fami l ies: 42 females, 53 males and one individual where the 
sex was not mentioned (references 1-3, 5-9, 11-14, 18-20, 22-28, 30-38, 
40, 42-50, 52-55). In these cases many di f ferent symptoms were reported 
(Fig. 5). In addition to progressive deteriorat ion after normal development 
in the f i rs t year and autosomal recessive inheritance, most authors include 
the fol lowing features as the main symptoms of CS: mental retardat ion, 
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Total (%) 
CDF 
57 
27 
20 
senile appearance, photosensitive dermatitis, dwarf ism, central motor 
disturbances, intracerebral calcifications, retinal pigmentdtion and peripheral 
neuropathy. In only 51% of the described cases were 6 or more of the 
main symptoms mentioned. The conclusion that there is a unique cluster 
oí diagnostic criteria, minimal and necessary for the diagnosis of CS, cannot 
be made. 
Detailed neuropathologic studies, as reported by Mooss;y( 1967),fíowíaíí( 1969), 
Crome and Kanjilal (1971), Sugarman et al (1977) and Soffer et al (1979), 
revealed central white matter atrophy with patchy demyclmation and 
preservation of axons. These authors also found extensive cxtravascular 
calcifications located in the basal ganglia, dentate nuclei, white matter 
and throughout the cortex. In vivo calcifications of the basal ganglia, 
visible on skull radiograms, were reported in 25 cases (references 1, 3, 
7, 18, 22, 26, 32, 35, 36, 42, 49). On CT scanning they were visible in 
3 cases ( ßrumback et al 1978, Jin et al 1979). As far as we know, cerebel-
lar calcifications have until now not been detected on CT scanning m 
CS. Calcifications of the basal ganglia have also been reported in para-
thyroid dysfunction and cerebral anoxia ( Löwenthal and Bruyn 1968). In re-
viewing the literature, Boiler et al (1977) found 9 families with idiopathic 
familial basal ganglia calcifications, and added one more family to this 
list. 
Peripheral nerve conduction velocities were normal in 3 cases ( Ohno and 
Hirooka 1966, Sugarman et al 1977) and slowed m 15 cases (references 
1, 3, 7, 19, 22, 32, 44, 47). In 7 cases nerve biopsies had been performed, 
showing chronic demyelinatmg neuropathy in 3 cases ( Moosa and Dubowitz 
1970, Roy et al 1973). Normal findings were described by Gamstorp (1972), 
See et al (1974), and Jm et al (1979). 
In our cases, all the main symptoms of CS were present, except for micro-
cephaly and retinal pigmentation. The results of VECP and color vision 
examinations may be interpreted as symptoms of the desynchromsation 
of the conductive system, pointing to optic neuropathy. There were no 
signs of compressing optic neuropathy, so these findings may be due to 
a genuine demyelinatmg process of the optic conductive system. The VECP 
alterations and color vision disturbances (e.g. FM 100 Hue error score) 
increased with age, suggesting a progressive disease. 
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Fig. 3 Sural nerve fiber diameter spectra in 3 siblings with Cockayne's 
syndrome and controls 
The audiograms showed perceptive high tone losses, also increasing with 
age. When audiometrie losses are caused by middle ear lesions or when 
high tone losses are caused by cochlear lesions, a shift of the whole nerve 
pattern in the BAER may occur due to a slowing of the 0-1 latency (repre­
senting action potentials from the acoustic nerve). However, slowing of 
the interpeak latencies represent brainstem nerve conduction delay and 
thus retrocochlear lesions. In our study, we clearly observed increased 
interpeak latencies, which lead us to the conclusion that the perceptive 
high tone losses are at least of retrocochlear origin. Not only the high 
tone losses, but also the interpeak latencies increased with age, suggesting 
a progressive retrocochlear disease of the auditory pathway. 
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Fig. b This electron-micrograph shows that almost all myelinated fibers 
are surrounded by one or more layers of Schwann cell processes which 
form so-called onion-bulbs. Several thinly myelinated fibers are seen, 
indicating remyelination. The unmyelinated fibers don't show any abnorma­
lities. 1700 χ 
Some aspects of the peripheral demyelinating neuropathy also showed 
an increase with age. Onion-bulbs as non-specific signs of repeated de-
and remyelination Dyck 1975) were most pronounced in the eldest patient 
and barely noticeable in the youngest. The same is true for the incidence 
of de- and remyclinated segments in teased fibers (Table IV), which was 
inversely correlated with the nerve conduction velocit ies. The decrease 
case 
S1 
α. E 
mental retardation 
microcephaly 
central motor disturoances* 
intra cranial calcifications 
deafness 
dysarthria 
peripheral neuropathy 
nystagmus 
hydrocephalus 
disturbed EEC 
dwarfism 
senile appearance 
carious teeth 
disproportionate extremities 
kyphosis 
undescended testicles* · 
prognathism 
large prominent ears 
. hepato and 'or splenomegaly 
photosensitive dermatitis 
loss of subcutaneous fat 
acrohypothermia 
diminished sweating 
retinal pigmentation» 
optic atrophy 
cataract 
dim resp to mydriatics 
l diminished tearing 
50 
Fig. 5 Frequency of symptoms described in Cockayne's synd 
1Ш 
Irò me 
^в^шв present 
х- -^ ч not present 
ι ι not mentioned 
и irrelevant 
* ругатиііаі and/or extrapyramidal and/or 
cerebp|inrsians 
** thickened skull bones and/or calcifications of the 
basal ganglia 
*»* 100% = 53 male cases (all olher items 
100% = 96 cases) 
in m y e l i n a t e d f i b e r d e n s i t y and the r e d u c t i o n in d i a m e t e r s of t h e l a r g e s t 
m y e l i n a t e d f i b e r s w e r e n o t e v i d e n t l y c o r r e l a t e d w i t h age ( F i g . 3). T h e 
d e c r e a s e in l a r g e d i a m e t e r m y e l i n a t e d f i b e r s , as seen in our cases, is 
a w e l l k n o w n f a c t in o t h e r d e m y e l i n a t i n g n e u r o p a t h i e s and is m o s t p r o b a b l e 
an n o n - s p c c i t i r r e s u l t of r e p e a t e d de- and r e m y e l m a t i o n ( K ä m e 1978). Type 
g roup ing , as seen in the musc le biopsies, is a consequence of axona l loss 
r a the r than t h e resu l t o í de - and r e m y e l m a t i o n . I t is l i ke l y t h a t axona l 
loss is a secondary result, the primary being the de- and rcmyel inal ing 
proc ess. 
In our rases, the c l in ical , neurotadiologic, electroneurographic and histo­
pathologic disturbances increased with age, suggesting л progressive disease. 
Demyelnat ion of the peripheral nerve was proved by the nerve biopsy 
findings, while demyelination in the central nervous system was suggested 
by ophthalmologic and audiologic findings. The concurrence of demyelination 
of the peripheral and central nervous system points to a disturbance of 
myelin or myelinating cells, as seen in some leukodystrophies. Our obser­
vations strongly support the theory, as proposed by Moosa and Dubouitz 
(1970), of Cockavne's svndrome being a leukod\strophy. 
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CHAPTER V 
PRESENCE OF CEREBRAL PARATHYOID HORMONE-
RESPONSIVE ADENYLCYCLASE IN HUMANS 
M. Smits, R. de Abreu, P. Froehng, 
F. Gabreëls 
Ann. Neurol. (1983) 14: 348-349 

Adenylcyclasc plays an important role in many extracerebral and cerebral 
metabolic pathways by act ivat ing the transformation of adenosine triphos­
phate into cycl ic adenosine monophosphate (cAMP). This enzyme can be 
st imulated by a number of d i f ferent hormones [ 1 , 3, *+, 9|. 
The presence of renal paratyroid hormone (PTH)-responsive adenycyclase 
has been demonstrated by the administration of PTH; such administration 
resulted in increased urinary production of nephrogenous cAMP [5] . Demon­
stration of cerebral PTH-responsive adenycyclase, however, has not vet 
been described. In order to determine if a cerebral PTH-responsive adenyl-
cyclase exists, the e f f e c t of PTH on cerebrospinal f lu id (CSF) cAMP concen­
trations was studied. 
One healthy 21-year-old man and two healthy women, ^5 and 56 years 
old, remained at complete bedrest after an overnight fast prior to intra­
venous injection of 700 IU of bovine PTH (Hormon-Chemie, Munich). A 
d i f ferent hormone batch was used for each person. Lumbar punctures 
were performed as described pre\ lously [2]. The needle remained in position 
for 30 minutes. Simultaneous blood and CSF samples were obtained prior 
to and every 5 minutes after PTH njection. Sei urn and CSF samples were 
frozen at -20oC immediat i) a l ter termination of the experiment. In the 
same way, C^c samples were collected in t i r - te oiner healthy adults prior 
to and after intravenous imection of saline. Measurement of c\\1P was 
done by high-performance liquid Chromate ^raphy '6|. Normal basal values 
for CSF cAMP were 13.^ >_ 9.0 nmol/L (mean ^ standard deviation) (n-
17). Detection accuracy was 2 nmol/L. 
The administration of PTH produced a f ive- to tenfold rise m plasma 
с AMP, which peaked 10 minutes after injection and then declined expo­
nential ly unti l 25 minutes after injection, when i t reached the in i t ia l 
prestimulation serum cAMP level. Simultaneously, during the 30 minutes 
after in ject ion, the CS cAMP concentrations increased significantly ( ρ <, 
0.003; Spearman's rank correlation test for each subject), as is shown 
in the Figure. A f t e r the saline injection, the CSF cAMP concentrations 
remained with in the normal basal range (see the Figure). 
This last observation indicates that the PTH-induced four- to sevenfold 
increase in CSF сЛМР concentration was not the consequence of a stress 
e f f e c t of the lumbar puncture and the systemic injection. Changes in 
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ι ι normal basal value ± SD 
Concentration-ti me curves of cyclic adenosine monophosphate in cerebrospi­
nal fluid after injection of parathyroid hormone (filled symbols) or saline 
(open symbols) 
CSF cAMP concentrations brought about by pharmacological agents ref lect 
alterations in the cerebral cAMP metabolism [2] . Thus, the observed PTH-
induced increase in CSF cAMP concentrations ref lects the increase in 
cerebral cAMP. Because cerebral cAMP formation is the direct consequence 
of st imulat ion of cerebral adenylcyclase [ 3 ] , our observation suggests 
the presence of cerebral PTH-responsive adenylcyclase. 
Hypofunction of this cerebral adenylcyclase might play a role in the cerebral 
dysfunction associated wi th hypoparathyroidism [7] . 
It is not l ikely that the intact PTH molecule, which is a single chain 
polypeptide of eighty-four amino acids [8|, is able to cross the blood-brain 
barrier. It is possible, however, that some biologically active fragments 
[8] could cross this barrier and reach their cerebral target organs. 
9a 
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CHAPTER VI 
CALCIUM-PHOSPHATE METABOLISM IN AUTOSOMAL 
RECESSIVE IDIOPATHIC STRIO-PALLIDO-DENTATE CALCINOSIS 
AND COCKAYNE'S SYNDROME 
M. Smits, F. Gabreëls, P. Frocl ing, R.A. de ЛЬгеи 
H. Thiibscn and Vt. Renier 
Cl in. Neurol. Neurosurg. (1983) S5: 1'+5-ПЗ 
SUMMARY 
In three siblings wi th autosomal recessive idiopathic stno-pal l ido-dentate 
calcinosis (SPDC) and in three other siblings wi th Cockayne's syndrome 
(CS) studies on plasma values of calcium and phosphate, intestinal calcium 
absorption, radiograms of the hands and studies on the influence of parathyroid 
hormone (PTH) on the renal threshold for phosphate revealed no abnormali-
ties. In one of the SPDC patients and one of the CS patients the ef fect 
of PTH on the cycl ic adenosine monophosphate (cAMP) concentrations in 
urine and cerebrospinal f lu id (CSF) were determined. In both a normal respon-
se of urinary cAMP was noted. In the CS patient the response of CSF cAMP 
was also normal. The SPDC patient, however, had a signif icantly decreased 
response of CSF cAMP. 
I t is suggested that a decreased sensit ivity of the cerebral anenylate cyclase 
complex is involved in the etiology of autosomal recessive idiopathic SPDC 
Subsequently this order could be considered as cerebral pseudohypopara-
thyroidism. The etiology of CS remains unknown. 
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INTRODUCTION 
Autosomal recessive idiopathic strio-pallido-dentate calcinosis (SPDC) 
is characterized by calcification in the strio-pallido-dentate system, extra-
pyramidal and cerebellar signs and mental deterioration ( Löwenthal and 
Bruyn ; 1968). Results of extensive biochemical investigations of patients 
with idiopathic SPDC are usually within the normal range (Löwenthai and 
Bruyn, 1968; Smits et al., 1983a). 
Autosomal recessive Cockayne's syndrome (CS) is characterized by the 
same svmptoms us autosomal recessive idiopathic SPDC and, in addition, 
Ь\ dvbdrhsm, senile· appearance, microcephaly, signs of central and peri­
pheral mvelinopathv. photosensitive dermatitis, retinitis pigmentosa and 
many other somatic abnormalities ( Soffer et al, 1979; Smits et al., 1982a). 
Hypoparathyroidism may be associated with the neuroradiological and 
clinical signs of autosomal recessive idiopathic SPDC and, in addition, 
may be associated with epilepsy and tetany Frame, 1976; Smtts et al., 
1982b). 
Biochemically, hypoparathyroidism is characterized by hypocalcemia and 
hyperphosphatemia due to either a deficient secretion of parathyroid hor­
mone (PTH) (primary or surgical hypoparathyroidism) or unresponsiveness 
of the receptor to PTH (pseudohypoparathyroidism). 
Because (pseudo)hypoparathyroidism is the only known metabolic disorder 
associated with calcification in the strio-pallido-dentate system, it has 
been suggested that idiopathic SPDC and CS are the consequence of a 
disorder in the PTH-regulated calcium-phosphate (Ca-P) metabolism ( Nyiand 
et al., 1977; Smits et al., 1982a). In three siblings with autosomal recessive 
idiopathic SPDC and in three other siblings with CS we tested this hypo­
thesis. 
MATERIAL AND METHODS 
Patients 
Three siblings with autosomal recessive idiopathic SPDC (S , S and S ), re­
ported m detail in an earlier study ( Smits et al-, 1983a), showed calici-
fications in the strio-pallido-dentate system (Fig. 1). At the time of our 
99 
Fig. 2 CT scans of patient S showing calcification in the basal ganglia 
and dentate nuclei 
investigations only the eldest si,owed additional neurological signs, i.e. 
mental deteriorat ion and progressive extrapyramidal and cerebellar signs 
(Table 1). The results of extensive biochemical tests on blood, urine and 
cerebrospinal f lu id (CSF) were normal. Radiograms oí the hands showed 
no abnormalit ies. 
Three other siblings with CS ( С , С^ and С ), reported m detail in an 
earlier study ( Smits et al . , 1982a), showed calcif icat ions m the stno-pal l ido-
dentate system (Fig. 2), mental deterioration p>iaii i.dai. ^ Tapyramidal 
and cerebellar signs, polyneuropathy (Table 1), dwarf ism, semit appearance 
and photosensitive dermat i t is. Disturbed visuu and br.nn m auditory 
evoked potentials indicated demyclination of the central nervous system. 
Except tor slightly elevated serum glutamic oxalate transferase, serum 
glutamic pyruvate transminasc and • Ύ glutamyl transpeptidase concen­
trations, the results of extensive blood and urinary investigations were 
normal, in patient С CSF was normal except for an 'ncreased protein con­
centrat ion (Z?1) rng/l). In patients С and С CSF was not investigated. 
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Table 1 Neurological findings in three siblings with autosomal recessive 
idiopathic strio-pallido-dentate calcinosis (S » S and S ) and three 
siblings with Cockayne's syndrome (C . С and С ) 
Panent 
Sex 
Age (\rs) 
Mental deterioration 
P\ramidal signs 
Exlrapvramidal and eerebellar signs 
Strio-pallido-dentate calcinosis 
Demyelination in CNS* and P N S · * 
s, 
F 
41 
+ 
— 
+ 
+ 
— 
S, 
M 
38 
-
-
— 
+ 
— 
s, 
M 
33 
-
— 
-
+ 
— 
Ci 
M 
19 
+ 
+ 
+ 
+ 
+ 
c, 
M 
16 
+ 
+ 
+ 
+ 
+ 
c, 
ι 
13 
+ 
+ 
+ 
+ 
+ 
F = female. M = maie. + = present. - = absent 
* central nervous svstem. ** peripheral nervous svstem 
Radiograms of the hands showed no abnormalities. 
In these six patients Ca-P metabolism was studied. 
Methods 
Plasma, urinary and CSF Ca concentrations were measured with the cre-
solphtalein complexone reation (Moorehead andßiggs, 197Ό and Ρ with the 
Fig. 2 CT scans of patient С showing calcification in the basal ganglia 
and dentate nuclei 
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continuous-flow ultraviolet spectrophotometer (Amador and Urban, 1972). 
Plasma and urinary creatinine with the 3affe reaction ( Henry et al., 197^) 
and magnesium (Mg) with the Perkin-Elmer atomic absorption spectrophoto­
meter 400. Plasma PTH and calcitomne concentrations were measured 
by a modified radioimmunoassay method, conducted by Dr. Hakking, Bergweg 
Hospital, Rotterdam, The Netherlands. Plasma 25 (OH) cholecalciferol 
and 1,25 (OH) cholecalciferol determinations by the high performance liquid 
chromatographic (HPLC) method of Eisman (1976) and CSF с AMP by 
the HPLC method of de Abreu et al., (1982). 
PTH stimulation tests were conducted as follows: 200 UI bovine PTH (Hor-
mon-Chemie Munich) was injected intravenously in the patients following 
an overnight fast. In all patients the same hormone batch was used. Blood 
and urinary samples were collected one hour before, just before and one, 
two and three hours after hormone injection for determination of the 
renal threshold for Ρ (TmP/GFR, see Bijvoet e t a l . , 1969) and cAMP. 
To correct for errors due to variation in the water content of urine, urinary 
concentrations of Ρ and cAMP were expressed as mmol/mol creatinine 
respectively as u mol/mol creatinine. In patients S . and C . some minutes 
before the PTH injection a lumbar puncture was performed m the lateral 
decubitus position with a 20-gauge needle that remained in position for 
30 minutes. CSF samples were obtained immediately prior to and every 
5 minutes after PTH admimsteration ( Srmts et al., 1983b). Immediately 
after termination of the PTH stimulation tests, serum, urine and CSF 
samples were stored at -2G0C for 3 to 4 weeks prior to cAMP assay. 
Intestinal Ca retention was measured by a modification of the method 
described by Sjöberg et al. (1970). Following a single dose of IOPCI Ca, gi-
ven with 200 ml milk as carrier, the percentage absorption of this dose 
was determined by monitoring the retention of the isotope over a 3-week 
period, using a whole body counter. 
RESULTS 
The results of biochemical investigations on serum, urine and CSF are 
shown in Table 2 and the results of the PTH stimulation tests are given 
in Table 3. All results were within the normal range. 
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Tabel 2 Serum, urine and cerebrospinal f l u i d (CSF) values of various parameters involved in calcium-phosphate 
(Ca-P) metabolism and intestinal Ca retent ion studies in three siblings w i t h autosomal recessive idiopathic 
strio-pall ido-dentate calcinosis (S , S and S ) and in three siblings w i t h Cockayne's syndrome (C , С and 
С
з
) 
norm.il 
F j l icnl S, S, S, ( , С. С , v.ilucs 
Л гкш Ca (mmol/1) 2 21 2^7 2 5.1 2 M) 2 Ч 2 M) 2 20-2 M) 
Ρ (mmol/1) OSI 0 KK KW I 04 122 119 0 76-124 
M g ( m m o l / l ) OKI 0 74 OHI OHI 0K.1 0 К5 0 НО-1 00 
Р І Н * (pmol Р У І ) 0 10 (MW ООН · 020 
PTH**(pmol P_,/l) 4 0 4 4 4 0 2 0-12 0 
OalutinmiMiig HCT/1) 0 06 0 12 021 0 02 0 02 0 02 ' 0 1.1 
25(OH)chi)lci.i lcil ' i:rol<ng/ml) 49 26 20 15 14 20 10-50 
1 25(()Н)^Ьо1С(.аІиІ'сгоГ(пц/КЮтІ) 56 J 4 4 1 4H 5 1 6 0 2 0-6 0 
Lune Ca (mmol/24 h) * 5 3 6 1 5 6 4 3 6 ^ 7 0 - 7 ι 
Mg (mmol/24 h) I I 15 15 14 16 12 - 1 0 
CSI Ca (mmol/1) I 08 I IH I 02-1 .12 
Mg (mmol/1) 0 49 0 50 0 37-0 *<> 
І т е м т л І С a retemionC; dose) 26 7 28 2 17 2 27 3 26 9 14 > 10 0 
* bmme parathsroid hormone ( I T U ) сциіч.іІоп( 
** human parath\ronl hormone ( I T U ) equivalent 
Table 3 Results of parathyroid hormone (PTH) stimulation tests performed in one sibling with autosomal recessive 
idiopathic strio-pallido-dentate calcinosis (S ) and three siblings with Cockayne's syndrome (C , С and 
С ) before (-) and after (+) intravenous injection of 200 IU PTH 
Panent 
l i m e (mm) 60 
5 
+ 60 
+ 120 
+ 180 
Ρ* 
130 
145 
2 37 
2 25 
120 
s, 
Tm Ρ/ 
C.ÍR 
0 80 
081 
0 64 
I 16 
I 21 
L A M P " 
041 
0 40 
42 30 
3 43 
0 43 
Ρ 
2 14 
1 71 
3 50 
4 66 
4 66 
f , 
Tm Ρ/ 
O l R 
1 13 
1 25 
1 I I 
1 06 
101 
(.4.MP 
2 0 
2 1 
50 0 
4 0 
33 
Ρ 
1 25 
147 
I 52 
3 48 
2 68 
f , 
TmP/ 
GFR 
163 
160 
1 53 
1 19 
1 38 
Ρ 
0 53 
0 58 
2 16 
2 83 
2 88 
t , 
ImP/ 
Ы R 
1 62 
1 60 
1 25 
1 32 
1 34 
* mmol P/mmol Lrealinine 
** μιτιοΙ cAMP/mmol creatinine 
normal basal value 
± SD = 13±9nmol/l (n=17) 
Fig. 3 Cerebrospinal fluid (CSF) cAMP concentrations in three healthy 
adults ( *·—··* ), in patient С with Cockayne's syndrome ( · · ) and in 
patient S with autosomal recessive idiopathic strio-pallido-dentate calci­
nosis ( « * ) after intravenous injection of 200 IU parathyroid hormone 
(PTH). The data for the healthy adults have been described previously 
(Smits et al., 1983b) 
The effect of PTH on CSF cAMP concentrations, examined in patients 
S and С and in three healthy adults (see Smits et al., 1983b), is shown 
ι ι 
in Fig. 3. According to Dixon's test ( Dijcon, 1950, 1951, 1953) the values 
observed in patient S are significant outliers (p < 0.05) for t = 20 minutes. 
For t = 25 minutes the value is nearly significant (0.0^< p< 0.10). 
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ATP 
extra cellular 
•second messenger 
Fig. * Schematic representation of the adenylate cyclase complex (RNC) 
and phosphodiesterase (PDE) which regulate intracellular levels of cAMP. 
The hormone (H) binds to the receptor (R) which than attaches to the 
GTP-nucleotide regulatory unit (N) and activates the catalytic component 
(C) of the adenylate cyclase complex to produce cAMP. PDE can be mem-
brane-bound or in the cytosol (adapted from Rodbell, 1980) 
PTH— 
BONE 1-
INTESTINE 
KIDNEY 
CEREBRUM 
bone turnover 
calcium absorption 
renal threshold for phosphite 
cerebrospinal f luid cAMP 
Fig. 5 Target organs and actions of parathyroid hormone (PTH) 
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DISCUSSION 
Ca-P metabolism is regulated and influenced oy many hormones and mine-
rals. PTH plays a central role in this mechanism. In the target tibsue 
for this hormone it stimulates the adenylate cyclase complex, which cata-
lyzes the conversion of adenosine triphosphate (ATP) into cAMP, a second 
messenger, which in turn activates specific biochemical pathways in the 
cel l (SutherÌand , 1972). Phosphodiesterase catalyzes the conversion of 
cAMP into adenosine monophosphate (AMP) (Fig. Ψ). In addition to st imu­
lation of the PTH-responsive adenylate cyclase complex, PTH may also 
regulate the Ca-P metabolism by other, largely unknown, mechanisms. 
The influence of PTH on Ca-P metabolism (Fig. 5) can be summarized 
as fol lows: 
a) PTH stimulates the hydroxylation of 25 (OH) cholecalciferol into 1,25 
(OH) cholecalc i ferol , which stimulates the intestinal Ca absorption. 
The intestinal Ca absorption can be studied by measuring the intestinal 
retent ion of Ca (Sjöberg et a l . , 1970). 
b) PTH stimulates the adenylate cyclase complex located in the bone cells 
and plays an important role in bone turn-over. Subperiostal erosions, 
visible on radiograms, are indicative for hypoparathyroidism. 
c) PTH stimulates the adenylate cyclase complex located in the renal proxi-
mal tubular cells. Stimulation results in an increase of urinary cAMP 
concentrations and a decrease in TmP/GFR ( Bijvoet et a l . , 1969). 
d) We have observed in three healthy adults that intravenously injected 
PTH resulted in an immediate rise in the CSF cAMP concentrations 
(Fig. 3). As there is a def in i te blood-brain barrier for cAMP ( Brooks et 
a l . , 1977), i t can be concluded that there exists a cerebral enzyme which 
stimulates the production of cerebral cAMP, i.e. a cerebral PTH-respon-
sive adenylate cyclase ( Smits et a l . , 1983b). 
The last observation, that of a cerebral adenylate cyclase sensitive to 
extracerebral ly administered PTH, raises intr iguing questions concerning 
the mechanism of this st imulat ion. PTH might act at sites in the brain 
where there is no blood-brain barrier for PTH. Al ternat ive ly , there could 
be specific transport mechanisms for PTH uptake by the brain, or extra-
cerebrally produced bioactive fragments of PTH might gain access to 
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the bram. Finally, the possibility must be considered that PTH might 
st imulate the production of extracerebral blood-born factors that can 
cross the blood-brain barrier to st imulate the cerebral adenylate cyclase 
complex. Further investigations are required to test these various possi­
bi l i t ies. 
In the present study the influence on extracerebral Ca-P metabolism was 
normal in al l our cases, as judged by the results of the investigations 
on plasma values of Ca and P, intestinal Ca absorption, radiograms of 
the hands and studies on the influence of PTH on TmP/GFR. Moreover, 
in patients S and С PTH produced a normal response of urinary cAMP, 
consistent w i t h a normal renal adenylate cyclase complex. 
The study on the e f f e c t of PTH on CSF с A M Ρ levels showed a normal 
response in the CS sibling С , but a signif icantly decreased response 
in the SPDC sibling S 15 minutes after hormone administration (Fig. 
3.). This decreased response could be due to leakage of CSF cAMP into 
the blood or by increased phosphodiesterase act iv i ty (see Fig. ¿f). However, 
the normal pre-st imulat ion CSF cAMP level indicates the existence of 
a normal blood-brain barrier. We would l ike to suggest that the decreased 
CSF cAMP levels m the SPDC patient could be due to a defect in the 
cerebral PTH-responsive adenylate cyclase complex. This defect could 
involve any component in the complex, including the receptor for PTH 
or the nucleotide regulatory unit ( see Fig. 4). Like in pseudohypoparathy-
roidism the (PTH-responsive) adenylate cyclase complex in kidney and bone 
is defect ive ( Aurbach , 1971), the defect ive cerebral PTH-responsive 
adenylate cyclase complex could be considered 'cerebral pseudohypopara-
thyroidism'. 
As autosomal recessive inheritance is usually associated wi th a gene defect, 
expressed as an enzyme deficiency, autosomal recessive idiopathic SPDC 
could be the consequence of a gene defect, through which a defect in 
the cerebral adenylate cyclase complex is produced. 
The etiology of CS remains unknown. 
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ADDENDUM 
Recently we studied a 13-year-old boy with autosomal dominant idiopathic 
SPDC. PTH injection did not change CSF cAMP, obtained in the above 
described way. Urinary cAMP response was normal. 
103 
REFhRCNCES 
1. Abreu, R.A. de, J.M. van Baal, С.НЛ1.М. de Bruyn, l .A.J.M. Bakkeren 
and E.D.A.M. Schretlen (1982): High-performance liquid chromatogra­
phic determination of purine and pynmidine bases, ribonucleosides, 
desoxynbonucleosides and cycl ic ribonucleotides in biological f luids. 
1. Chromatogr. 229: 67. 
2. Amador, E. and 3. Urban (1972): Simplif ied serum phosphorus analyses 
by continuous-flow ul trav io let spectrophotometry. C l i n . Chem. 18:601. 
3. Aurbach, C D . (1971): Pseudohypoparathyroidism. In: Beeson, P.B. 
and W. McDermott (Eds): Cecil-Loeb. Textbook of Medicine. Phila-
delphia-London-Toronto, W.B. Saunders Company, p. 1853. 
't. Bi jvoet, O.L.M., D.B. Morgan and P. Fourman (1969): The assessment 
of phosphate reabsorption. C l i n . Chem. Acta 26: 15. 
5. Brooks, B.R., W.K. Engel and 3. Sode (1977): Blood-to-cerebrospinal 
f lu id barrier for cycle adenosine monophosphate in man. Arch. Neurol. 
3k: 468. 
6. Dixon, W.3. (1950): Analysis of extreme values. Ann. Math. Stat. 21:488. 
7. Dixon, Ю . (1951): Ratios involving extreme values. Ann. Math. Stat. 
22: 68. 
8. Dixon, W.J. (1953): Processing data for outl iers. Biometrics 9: 74. 
9. Eisman (1976) 1,25 (OH) Cholecalciferol in biological f luids. A simpl i­
f ied and sensitive assay. Science 193: 1021. 
10. Frame, B. (1976): Neuromuscular manifestations of parathyroid disease. 
In: Vinken, P.J. and G.W. Bruyn (Eds): Handbook of Cl inical Neurology. 
Amsterdam, North-Holland Pubi. Co., vol. 27: 283. 
11. Henry, R.J., D.C. Cannon and J.W. Winkelman (1974): Automated deter­
mination of serum and urine creatinine. In: Cl inical Chemistry. New 
York, Harper and Row, p. 552. 
12. Ldwenthal, A. and G.W. Bruyn (1968): Calc i f icat ion of the stnopal l ido-
dentate system. In: Vinken, P.J. and G.W. Bruyn (Eds): Handbook of 
Cl inical Neurology. Amsterdam, North-Holland Pubi. Co., vol. 6: 703. 
13. Moorehead, W.R and H.G. Biggs (1974): 2-Amino-2-mcthyl-1-propanol 
as the alkal izing agent in an improved continuous-flow cresolphtalein 
complexone procedure for calcium in serum. Cl in. Chem. 20: 1458. 
Ι Ψ. Nyland, Η. and Η. Skre (1977): Cerebral calcinosis wi th late onset 
encephalopathy unusual type of pseudo-pseudohypoparathyroidism. 
Acta Neurol. Scand. 56: 309. 
15. Rodbell, M. (1980): The role of hormone receptors and GTP-regulatory 
proteins in membrane transduction. Nature (London) 284: 19. 
16. Sjoberg, H.E., P.Reizenstein and E. Arman (1970): Retention of orally 
administered Ca in man measured in a whole body counter. Scand. 
J . C l in. Lab. Invest. 26: 67. 
17. Smits, M.G., F.3.M. Cabreéis, W.O. Renier, E.M.G. Joosten, A.A.W.M. 
Gabreels-Festen, Н.Л. ter Laak, A.J.L. Pinckers, G.C.3. Hombergen, 
S.L.H. Notermans and H.O.M. Thijssen (1982a): Peripheral and central 
myelinopathy in Cockayne's syndrome. Report of 3 siblings. Neurope-
diatr ics 13: 161. 
18. Smits, M., F Cabreéis, P. Froeling, H. Thijssen, E. Colon, B. ter Haar, 
С. Ruland, R. ' t Lam (l982b):Autosomal dominant idiopathic hypopara­
thyroidism and nervous system dysfunction: report of three cases and 
review of the l i terature. 3. Neurol. 228: 113. 
19. Smits, M.G., F.3.M. Cabreéis, H.O.M. Thijssen, R.L. ' t Lam, S.L.H. 
Notermans, B.G.A. ter Haar and 3.3. Prick (1983a): Progressive idio-
pathic str io-pall idodentate calcinosis (Fahr's disease) wi th autosomal 
recessive inheritance. Report of three siblings. Eur. Neurol., 22: 58. 
20. Smits, M.G., R.A. De Abreu, P.G.A. Froeling and F.3.M. Cabreéis 
(1983b): Presence of cerebral parathynodhormone-responsive adenylcy-
clase in man. Ann. Neurol., in press. 
21 . Softer, П., H.W. Grotsky, I. Rapin and K. Suzuki (1979): Cockayne 
syndrome: unusual neuropathological findings and review of the l i tera­
ture. Ann. Neurol. 6: 340. 
22. Sutherland, E.W. (1972): Studies on the mechanism of hormone act ion. 
Science 117: f 0 1 . 
I l l 

CHAPTER VII 
CONCLUSIONS AND DISCUSSION 

7.1 Introduction 
Many di f ferent descriptions have been proposed on the symptomatology 
and etiology of str io-pal l ido-dentate calcinosis (SPDC) since its 
f i rs t mention by Virchov in 1856 (16). 
Skull radiographical studies of patients wi th SPDC have revealed 
that this very rare neuroradiological condition is often associated 
wi th a specific ent i ty of neurological signs, specif ically those that 
are extrapyramidal and cerebellar. These studies have also shown 
that SPDC is often associated wi th a disturbed calcium-phosphate 
(Ca-P) metabolism (especially hypoparathyroidism) (1 , 10, 12). 
On the other hand, studies of SPDC by the much more sensitive 
CT-scan have revealed conf l ic t ing results: the frequency of SPDC 
diagnosed on CT-scan appeared to be much higher (0,5-1,6 %) than 
previously observed (3, 8, 13, 17); most SPDC patients diagnosed 
by the CT-scan did not show extra-pyramidal and/or cerebellar 
signs (8, 13, 17). These CT-scan studies also showed that SPDC 
can be associated wi th many exogenous and endogenous ( fami l ia l 
and non-famil ial) factors (8, 17). The results of these studies convinced 
some researchers (9, 17) that SPDC, which is detected by chance 
by CT-scan, has no cl in ical signif icance, such as calc i f icat ion in 
the pineal gland and choroid plexus, which also have no cl in ical 
signif icance. 
In the last two decades new cl in ical neurophysiological and neuro-
morphological methods have increased understanding of the functioning 
and anatomy of the central and peripheral nervous system, while 
new endocrinological methods have increased the knowledge of 
Ca-P metabolism. This leads natural ly to the question of whether 
these same new methods could increase our knowledge of SPDC. 
In order to obtain a rather homogenous group of SPDC patients 
and to make i t possible to leave exogenous factors out of consideration 
we restr icted our studies on the symptomatology and etiology of 
SPDC to fami l ia l disorders with calci f icat ions in both basal ganglia 
and dentate nuclei. 
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Table I Extent of SPDC, represented as +, ++ and t + t in the two patients 
wi th autosomal dominant idiopathic hypoparathyroidism (HI and H2), the 
three patients wi th autosomal recessive idiopathic SPDC (S I , S2, S3) and 
the three patients wi th Cockayne's syndrome ( C I , C2 and C3) 
Patient Extent of SPDC 
HI + + 
H2 ++ 
51 + + + 
52 + + 
53 + 
CI
 + + 
C2 + + 
C3 + 
Fig. I . Skull radiograms of the eldest patient wi th autosomal recessive 
Idiopathic SPDC showing calci f icat ions in the basal ganglia and dentate 
nuclei. 
! 16 
Studying a father, his son and his daughter, all three having autosomal 
dominant idiopathic SPDC; three siblings with autosomal recessive 
idiopathic SPDC and three siblings with Cockayne's syndrome, we 
intended to answer the iollowing questions: 
a. Is familial SPDC characterized by a specific entity of neurological 
signs9 
b. Is a disturbance of the Ca-P metabolism involved in the origin 
of autosomal recessive idiopathic SPDC and Cockayne's syndrome7 
с Can indications be found for the presence of a cerebral parathyroid 
hormone (PTH)-responsive adenylcyclase complex 9 
d. Is the function of the cerebral PTH-rcsponsive adenylcyclase 
complex disturbed in autosomal recessive idiopathic SPDC and 
Cockayne's syndrome0 
7.2 Results of the studies on familial SPDC 
7.2.1 Answers to the preceding questions 
a. Is familial SPDC characterized by a specific entity of neurological 
signs9 
The neurological signs of the investigated patients with familial 
SPDC described in chapter II, III and IV have been summarized 
in table 1 and figs. l-b. 
Each patient differed in the extent and location of the cerebral 
deposits (fig. I, table 1) and in the nature of the clinical neurological, 
clinical neurophysiological and neuromorphological signs (fig. 2). 
There was no relation between age and extent of calcification (fig. 3). 
Also, the patients showing SPDC in similar intensities differed 
in the nature of the clinical neurological, clinical neurophysiological 
and neuromorphological signs (fig. 4). 
These findings indicate that familial SPDC is not characterized 
by a specific entity of neuroradiological, clinical neurological, clinical 
neurophysiological and/or neuromorphological signs. 
Calcifications in : 
Basal ganglia • • • ^ • • • н н я н и н ш н н н ш 
Dentate nuclei шшшшшшшаш^^^^шшшш^ЯЕШшт 
Radiation of the corpus callosum н ^ ι 
Clinical neurological signs : 
Extrapyramidal signs • • • • • ^ ^ • ^ ^ ^ ^ • H c i - z z z z p 
Cerebellar signs • ¡ ^ • • • • ^ н н н н в н ш .. '....j 
Mental retardation ^шшшЁЁштш^ш^тштшт 
Clinical neurophysiological signs : 
Abnormal EEG ι ^ ^ — — — ^ — ι 
Abnormal specific S S EP complex [^  '^s" 
Abnormal aspecific S SEP complex 
Abnormal VE Ρ 
Abnormal ВЕР 
Delayed nerve conduction velocities 
Neuromorphological signs : 
Abnormal muscle and nerve biopsies ^ ^ — — : з 
Number of patients 
• β Present 0 4 8 
η і з Absent 
. : Not mentioned 
Fig. 2. neuroradiological, c l in ical neurological, c l in ical neurophysiological 
neuromorphological signs in the 8 described patients w i t h f a m i l i a l 
SPDC. 
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Extent of 
S P D C 
1 1 1 
ι I ш I • • I • I • I 
10 20 30 40 50 60 
Age (yrs) 
Fig. 3. Representation of the relationship between extent of SPDC and 
age of the described patients with familial SPDC. 
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EXTENT OF SPDC : + + + + + + 
Calcifications i n : 0 1 2 0 5 
Basal ganglia 
Dentate nuclei 
Radiation of the corpus callosum 
Clinical neurological signs: 
Extrapyramidal signs 
Cerebellar signs 
Mental retardation 
Clinical neurophysiological signs.· 
Abnormal EEG 
Abnormal specific S SEP complex 
Abnormal aspecific SSEPcomplex 
Abnormal VEP 
Abnormal ВЕР 
Delayed nerve conduction velocities 
ι 
Ί 
Neuromorphological signs: 
Abnormal muscle and nerve biopsies • • • ш и ^ м а н ι 1 
0 1 
Number of patients: , , , , , , _ , , , 
0 2 0 2 5 
ШЕЕвт Present 
ι 1 Absent 
• Not mentioned 
Fig. U. Neuroradiological, c l in ical neurological, c l in ical neurophysiological 
and neuromorphological signs in groups of patients w i t h f a m i l i a l SPDC 
showing each SPDC in about similar intensions. 
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Is a disturbance of the Ca-P metabolism involved in the origin 
of autosomal recessive idiopathic SPDC and Cockayne's syndrome? 
In autosomal recessive idiopathic SPDC and Cockayne's syndrome 
the Ca-P metabolism was studied wi th the fol lowing methods: 
measurement of the serum concentration of Ca, Ρ, calci tonin, 
PTH, 25 OH cholecalciferol and l,25(OH)
 ¿ cholecalci ferol ; deter-
mination of the intestinal absorption of calcium; study of the 
influence of PTH on the renal threshold for phosphate (TmP/GFR); 
measurement ot the calcium and phosphate concentrations in 
the cerebrospinal f lu id (CSF) and examination of radiograms 
of the hands. In addit ion, the influence of PTH on the urinary 
cAMP concentrations was investigated in a patient wi th Cockayne's 
syndrome and a patient with autosomal recessive idiopathic SPDC. 
Using these methods we could not f ind any disturbance of the 
Ca-P-metabolisr.-. in patients having autosomal recessive idiopathic 
SPDC and Cockayne's syndrome (chapter VI). 
Can indications be found for the presence of a cerebral PTH-
responsive adenylcyclase complex7 
The presence of the renal PTH-responsive adenylcyclase complex 
can be demonstrated by the administration of PTH. This results 
in an increased urinary production of cycl ic adenosine mono-
phosphate (cAMP) (5). 
In order to know if a cerebral PTH-responsive adenylcyclase 
complex exists, we studied the ef fect of PTH on CSF cAMP 
concentrations. 
In three healthy adults, PTH produced a k-7 fold increase in 
CSF cAMP concentrations while saline injection did not increase 
CSF cAMP concentrations, (chapter V). This latter f inding suggests 
that PTH-induced CSF с AM Ρ increase is not the consequence 
of a stress e f f e c t . As CSF cAMP is produced in the brain (k), 
our observations suggest the presence of a cerebral PTH-activated 
complex that induces cAMP production. In analogy wi th the renal 
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PTH-responsive adenylcyclase complex we suggest that this complex 
is a cerebral PTH-responsive adenylcyclase complex. 
d. Is the function of the cerebral PTH-responsive adenylcyclase 
complex disturbed in autosomal recessive idiopathic SPDC and 
Cockayne's syndrome? 
In a patient wi th autosomal recessive idiopathic SPDC and in 
a patient w i th Cockayne's syndrome we studied the function 
of the PTH-responsive adenylcyclase complex (chapter VI). 
In the patient wi th autosomal recessive idiopathic SPDC, PTH 
produced a normal response of CSF cAMP while in the Cockayne's 
syndrome patient the response was normal. 
These findings indicate that the sensit ivity of the cerebral PTH-
responsive adenylcyclase complex is decreased in autosomal recessive 
idiopathic SPDC while the PTH-responsive adenylcyclase complex 
functions normally in Cockayne's syndrome. 
Some additional results 
In all three patients wi th autosomal dominant idiopathic hypopara-
thyroidism (IHPT), epilepsy was the f i rs t manifestation of the disease 
(chapter IV). Two patients showed mental deteriorat ion and str io-
cerebellar signs. Their CT-scans revealed calc i f icat ion of the basal 
ganglia and dentate nuclei, which seemed to increase during normo-
calcemia produced by dihydrotachysterol therapy. This indicates 
that other factors than merely hypocalcemia influenced the cerebral 
calc i fy ing process. 
Somatosensory evoked potential studies, conducted in patients wi th 
autosomal dominant IHPT and sporadic IHPT (chapter IV), revealed 
an abnormal non-specific complex, indicating a dysfunction of the 
cort ical gray matter. 
The studies on autosomal dominant IHPT (chapter IV) indicate that 
in the evaluation of hypoparathyroidism, one must be aware of 
the possibility of epilepsy, mental deter iorat ion, stno-cerebellar 
signs, SSEP disturbances and SPDC. 
In the fami ly wi th autosomal recessive idiopathic bPDC the youngest 
patient had calci f icat ions only in the dentate nuclei and pons, while 
his elder siblings had additional calci f icat ions in the basal ganglia 
and radiation of the corpus callosum (chapter 11). These latter ca lc i -
f icat ions were the most pronounced in the eldest. This suggests 
that in autosomal recessive idiopathic SPDC the calci fy ing process 
is progressive. I t probably begins in the dentate nuclei and pons 
and subsequently spreads to the basal ganglia and radiation of the 
corpus callosum. 
In addit ion, in the siblings with Cockayne's syndrome the extent 
of the calci f icat ions increased wi th age, indicating that the ca l -
c i fy ing process is progressive. No conclusions can be drawn, however, 
on the course of this calc i fy ing process. 
Reviewing the l i terature for Cockayne's syndrome (chapter III), 
we found 96 recorded cases f rom 66 famil ies. This rat io is in agree-
ment wi th the hypothesis that Cockayne's syndrome is autosomal 
recessively inherited. The main symptoms are: a progressive deterio-
ration after a normal development during the f i rs t year of l i fe , 
microcephaly, dwarf ism, senile appearance, photosensitive dermat i t is , 
central motor disturbances, SPDC, ret inal pigmentation and peripheral 
neuropathy. Since only 51 percent of the described cases had six 
or more of these main symptoms, a minimal and unique cluster 
of diagnostic cr i ter ia is not possible. Laboratory investigations 
have not revealed any consistent abnormalit ies. 
The Cockayne's syndrome siblings, described in chapter I I I , displayed 
all these above-mentioned symptoms, except for microcephaly and 
ret inal pigmentation. Studies on brainstem auditory evoked potentials, 
visual evoked potentials and colorvision showed abnormalities which 
increased wi th the age of the siblings and which were consistent 
wi th demyelmation of the central white matter. Nerve and muscle 
biopsies revealed a demyelmation of the peripheral nerves, which 
also increased wi th age (chapter III). The concurrence of a demyel i-
nation of the peripheral and central nervous system points to a 
disturbance of the myelin or myelinating cells, also seen in some 
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leukodystrophies. Our observations strongly support the theory pro-
posed by Moosa and Dubowitz (II) of Cockayne's syndrome being 
a leukodystrophy. The increase wi th age of the neurological dis-
turbances, diagnosed by the neuroradiological, evoked potentials, 
color vision and eiectro-neurographical studies, indicates that these 
non-invasive methods can help evaluate the progression of the disease. 
Discussion 
CT-scan studies of the fami ly having siblings suffering f rom idiopathic 
SPDC suggested autosomal recessive inheritance. However, i t is 
possible that the apparently unaffected family-members have cerebral 
calc i f icat ions, the degree of which was beyond the detectionlevel 
of our CT-scanner (see appendix) at the t ime of the investigation. 
Neurological studies of the famil ies wi th autosomal dominant idiopathic 
hypoparathyroidism, autosomal recessive idiopathic SPDC and 
Cockayne's syndrome suggest that in these disorders the calci fy ing 
process is progressive. Prospective studies with the method described 
in the appendix may conf i rm this progression. 
CT-scans of the patients wi th fami l ia l SPDC revealed that in ad-
dit ion to calci f icat ions in the str io-pal l ido-dentate system, other 
parts of the brain can also be involved in the calci fy ing process. 
Subsequently, one must be aware that the name "str io-pal l ido-dentate 
calcinosis" may also imply cerebral calci f icat ions outside the str io-
pall ido-dentate system. 
The studies on autosomal dominant IHPT (chapter II) revealed neuro-
logical signs, which can be evaluated easily by CT-scan and somato-
sensory evoked potent ial studies. These techniques may become 
useful tools in the evaluation of hypoparathyroidism and its therapy. 
The presence of a cerebral PTH-responsive adenylcyclase complex 
(chapter V) raises intr iguing questions concerning its location and 
funct ion. The immediate response of CSF cAMP after st imulat ion 
by intravenously injected PTH suggests that PTH (or bioactive f rag-
ments of this hormone) can cross the blood-brain barrier to act ivate 
an adenylcyclase complex that is in close association wi th CSF. 
The analogy with the renal PTH-responsive adenylcyclase complex 
suggests that the cerebral FTH-responsive adenylcyclase complex 
is involved m the regulation of the cerebral Ca-P metabolism. 
In the Cockayne's syndrome patients we could not f ind any dis-
turbance of the Ca-P metabolism, nor could we f ind any other 
metabolic disorder (chapter III). The function of the cerebral PTH-
responsive adenylcyclase complex seemed to be normal (chapter VI). 
As our study involved only one patient wi th Cockayne's syndrome 
and normal values were obtained f rom only three persons, a degree 
of caution is required in making this conclusion. Recently Vos et 
al (18) found indications of lysosomal pathology in sural nerve biopsies 
f rom our and other Cockayne's syndrome patients, i t is pos ib le 
that further studies of lysosomes f rom Cockayne's syndrome patients 
could help elucidate pathological factors. 
In autosomal recessive idiopathic SPDC, no abnormalit ies of the 
Ca-P metabolism could be detected also (chapter VI). However, 
the decreased sensit ivity of the cerebral PTH-responsive adenylcyclase 
complex, which we noted in the investigated patient (chapter VI), 
suggests that a defect ive cerebral PTH-responsive adenylcyclase 
complex is involved m the etiology of autosomal recessive idiopathic 
SPDC. As the cerebral PTH-responsive adenylcyclase complex not 
only seems to be defect ive in autosomal recessive idiopathic SPDC, 
but also in autosomal dominant IHPT (see addendum chapter VI), 
the defect can probably be located at d i f ferent places in the cerebral 
PTH-responsive adenylcyclase complex. 
It is possible that some of the neurological signs of hypoparathy-
roidism are produced by hypofunction of the cerebral PTH-responsive 
adenylcyclase complex. This hypofunction could be produced by 
the lack of b io-act i \e parathyroid hormone (which occurs in "surgical" 
hypoparathyroidism and idiopathic hypoparathyroidism) or by a decreas-
ed sensit ivity of the PTH-responsive adenylcyclase complex (which 
occurs in pseudo-hypoparathyroidism). We suggest that a defective 
cerebral adenylcyclase complex is involved in the neurological sympto-
matology of both fami l ia l idiopathic SPDC and hypoparathyroidism. 
I t is probable that the cause of the neurological symptomatology 
of these two disorders is not related to the cause of the sympto­
matology of Cockayne's syndrome. 
The way in which the defective PTH-responsive adenylcyclase complex 
produces SPDC is not known, nor is there any understanding as 
to why the stno-pallido-dentate system becomes especially 
calcified. 
In SPDC patients many different neurological signs can be present 
and many different disorders can be diagnosed. This difference 
in symptomatology does not mean that SPDC has no clinical signifi­
cance. In view of the fact that few SPDC patients have been described 
without any neurological sign, we are of the opinion that SPDC 
is a sign of cerebral dysfunction. Its presence warrants investigation 
of the Ca-P metabolism, anoxic and toxic factors and familial oc­
currence. When more is know about the function of the cerebral PTH-
responsive adenylcyclase complex, an investigation of this complex 
in SPDC patients might throw new light on the origin of SPDC. 
7Λ Conclusions. 
From the results of the studies, presented in this thesis, the following 
conclusions can be drawn: 
I. 1. The neuroradiological sign 'stno-pallido-dentate calcinosis' is a 
sign of cerebral dysfunction. Its presence warrants investigation 
of the calcium-phosphate metabolism, axoxic and toxic factors 
and familial occurence. 
2. The familial neuroradiological sign 'stno-pallido-dentate calcinosis' 
is not associated with a specific complex of neurological signs. 
II. 1. Autosomal recessive idiopathic stno-pallido-dentate calcinosis and 
Cockayne's syndrome are not associated with a disturbance in the 
calcium-phosphate metabolism. 
2. A human cerebral parathyroidhormone-responsive adenylcyclase 
complex is likely to exist. 
3. Dysfunction of the cerebral parathyroidhormone-responsive adenylcy­
clase complex is probably involved in the etiology of autosomal 
126 recessive idiopathic stno-pallido-dentate calcinosis. 
REFERENCES 
1. Rernct J . С , Maf fly R.H., bteinbach H.L.: The significance of bilateral 
basal ganglia calcification. Radiology 72: 36S-378 (1959). 
2. Boller F., Gilbert 3.: Familial idiopathic cerebral calcifications. 
3. Neurol. Neurosurg. Psychiat. 40: 280-285 (1977). 
3. Brannen T.S., Burger A.A., Chaudhary M.Y.: Bilateral basal ganglia 
calcifications visualized on CT-scan. 3. Neurol. Neurosurg. Psychiatry 
43: 403-406 (1980). 
4. Brooke B.R., Engel W.K., Sode 3.: Blood-to-cerebrospinal fluid barrier 
for cyclic adenosine monophosphate in man. 
Arch. Neurol. 34: 468-469 (1977). 
5. Chase L.R., Aurbach G.D.: Parathyroid function and renal excretion 
of 3', 5' adenylic acid. Proc. Natl. Acad. Sci USA 58: 518-525 (1967). 
6. Danziger Α., Kalk U.3., Sandler M.P., Forman M.: Computer tomography 
in basal ganglia calcification. Clin. Radiol. 31: 167-168 (1980). 
7. Frame B. Neuromuscular manifestations of parathyroid disease. In: 
Vinken P.3., Bruyn G.W., eds. Handbook of Clinical Neurology, 
Vol. 27. Amsterdam: North-Holland, pp 283-320 (1976). 
8. Koller Vt . C , Cochran 3., Klawana H.L.: Basal ganglia calcification. 
Computerized tomography and clinical correlation. Neurology (Minnsap) 
29: 328-333 (1979). 
9. Koller W.C, Klawans H.L.: Cerebellar calcification on computerized 
tomography. Ann. Neurol. 7: 193-194 (1980). 
10. Lówenthal Α., Bruyn C.W.: Calcifications of the strio-pallido-dentate 
system. In: Vinken P.3., Bruyn G.Vl·. eds. Handbook of Clinical Neurology, 
vol. 6. Amsterdam: North-Holland, pp 703-725 (1968). 
11. Mooser Α., Dubowitz V.: Peripheral neuropathy in Cocksyne's syndrome 
Arch. Dis. Child. 45: 674-677 (1970). 
12. Muenter M.D., Whisnant 3.P.:Basal ganglia calcification, hypopara­
thyroidism, and extrapyramidal motor manifestations. Neurology 
(Vlmnsap). 18: 1075-1083 (1968). 
13. Murphy M.3.: Clinical correlations of CT-sc an-detected calcifications 
of the basal ganglia. Ann. Neurol 6: 507-511 (1979). 
líf. Palubinskas А.Л., Davies H.: Calcification of the basal ganglia of the 
brain. Am. 3. Roentgenol. 82: 806-822 (1959). 
15. Sachs C , Sjöberg H.В., Ericson К.: Basal ganglia calcifications on 
CT. Relation to hypoparathyroidism. Neurology (Ny) 32: 779-782 (1982). 
16. Virchow R.: Kalkmetastasen. Virchows Arch. (Pathol. Anat.) 
6: 618-620 (1856). 
17. Vlas 3.S.H., Lodder 3., van der Lught P.J.M.: Clinical significance 
of basasi ganglia calcifications detected by CT. (A retrospective study 
of 33 cases). Clin. Neurol. Neurosurg. 83: 253-256 (1981). 
18. Vos Α., Gabreëls-Feston Α., Doosten Ε., Gabreëls F., Renier %., 
MuUaert R.: The neuropathy of Cockne's syndrome. Acta Neuropath. 
61: 153-156 (1983). 
128 
APPENDIX 
QUANTIFICATION OF CT SCAN-DIAGNOSED 
CALCIFICATIONS 
Μ.Α.O. Thijssen 
[M.G. S m i t s 

1. Introduction 
The CT-scan is the best method by which to diagnose cerebral calcifi­
cations in vivo. Although smaller cerebral calcifications can be detected 
with this technique than by skull radiograms, it is likely that minute 
cerebral calcifications cannot be seen. The minimal extent of a calcifi­
cation, which can be distinguished by the CT scanner, is determined 
by the detection level of the used scanner. CT scan not only enables 
the detection of cerebral calcifications but also makes it possible 
to measure reasonably well the extent of the calcifications. This suggests 
that it should be possible to measure the amount of calcium in the 
calcifications. In this appendix we will discuss factors known to influence 
the detection level of CT scan-diagnosed calcifications. We will also 
discuss how it could be possible to determine the calcium content 
of these calcifications. 
2. Factors involved in the quantification of CT scan-diagnosed calcifications 
The detection of cerebral calcifications by CT scan is determined 
by the difference in the absorption of roentgen radiation between 
the calcification and the surrounding tissue. Absorption is characterized 
by the absorption coefficient ν . This absorption is measured by the 
CT scanner and is expressed as Houndfield Units (HU) according to 
the relation 
w χ - υ a 
HU - χ 1000 
u a 
Μ χ = absorption coefficient of the tissue 
u a = absorption coefficient of water 
The CT scanner transfers these HU into certain intensities of white 
which are shown on the monitor. Calcification is expressed as the 
lighter part while brain tissue is darker. The brightness of the monitor 
picture can be regulated. Subsequently, the detection threshold or 
discrimination between the two different tissues only depends upon 
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the properties of the used CT scanner and the definition of that thres­
hold. 
It is important to realise how a calcification in a CT scan slice is 
"seen" by the CT scanner and what the relationship is between the 
calcium concentration and the associated Houndsfield value. 
In order to quantify a CT scan-detected cerebral calcification, we 
will first discuss the way in which the CT scanner measures a ball-
shaped calcification and expresses this calcification in HU (partial 
volume effect). We will then give a definition of discrimination between 
two different types of tissue and describe the relevant properties 
of our Delta-FS scanner. Thirdly, we will describe how the diameter 
and the density of a barely visible calcification can be determined. 
Finally, we will discuss how to determine the calcium content of this 
barely visible calcification. Using these guidelines it will be possible 
to calculate reasonably well the amount of calcium in a certain calcifi­
cation. 
О 
Fig. 1. schematic representation of a ball-shaped particle as "seen" by 
the CT scan. 
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a. The partial volume effect. 
A ball-shaped part ic le having a higher absorption than its surrounding 
tissue can be seen on the CT scan monitor as a bright discus ( f ig . 
1). This thin discus does not represent the absorption of the bal l-
shaped part ic le, but i t does represent the tota l absorption of a 
cylinder wi th the same diameter as the ball-shaped part ic le and 
wi th a height, which is the same as the slice thickness of the CT 
scan ( f i g . 1). Subsequently, the reproduced HU value is the average 
of the HU value of the ball-shaped part ic le and the HU value of 
the rest of the cylinder (part ial volume). In formula: 
ни . =
 V b a 1 1
 ни . „
 +
 V c y l
 "
 V b a l 1
 HU 
cyl y ball y ^ surr. 
c y l . v b a ] l 
4/3 тгг 3 ν r 2 h 4/3 if r 3 
HU = _ _ H U b a l l + H U s u r r . 
π r h π r h 
V , ,, = Volume of the ball ball 
V . = Volume of the cylinder 
HU . - HU value of the cylinder 
HU = HU value of the surrounding tissue 
surr ö 
r = Radius ball = D/2 = half diameter 
h = Height cylinder = slice thickness 
When in brain tissue, whose absorption is 35 HU, a ball-shaped part ic le, 
whose absorption is 250 HU and whose diameter is 10 mm, is scanned 
wi th a slice thickness of 13 mm, this part ic le is represented as a 
thin slice wi th a diameter of about 10 mm and an average absorption 
of: 
HU , = 35 + ^ X 5 (250 -35) = 145,3 HU. 
^
1
 З ^ Л З 
Thus every measured absorption of a calc i f icat ion has to be corrected 
for the part ia l volume e f f e c t . When the diameter of the calc i f icat ion 
is more than 13 mm, the exact HU value can be measured direct ly 
in the centre of the ca lc i f icat ion. 133 
b. Discrimination between two d i f ferent tissues. 
To be able to discriminate between two tissues, the average HU 
value of one tissue has to d i f fer suft ic ient ly f r o m the other tissue. 
These values d i f fer suff ic ient ly when the di f ference between the 
m l and m2 values is more than the sum of the standard deviation of 
both tissue values ( f i g . 2). 
type A type β 
mj m2 HU 
Fig. 2 discrimination between tissue Λ and В is possible when the dif­
ference between m values is more than the sum of the standard 
deviation (SD) of both tissue values. 
Because of the f i n i t e exactness of the CT scanner measurements, 
the average value and the standard deviation depend upon the diameter 
and density of the part ic le. Small cylinders have to have higher 
absorption values to be seen on the monitor, than larger cylinders. 
The relationship between diameter and density of cylinders which 
just can be seen, is represented by the contrast-detai l curve. Fig. 
3 represents the contrast-detai l curve of our CT scanner, as i t was 
measured by M.A.O. Thyssen. 
Using the contrast-detai l curve i t is possible to calculate the de­
tect ion level of the calc i f icat ion wi th a certain diameter and a certain 
maximal HU value. In table 1 the underlined values represent the 
diameter of a just barely visible calc i f icat ion with a certain maximal 
HU value. Any part ic le wi th a higher HU value or a greater diameter 
can be seen wi th the Delta-FS CT scan. 
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Fig. 3. contrast-detail curve of the Delta FS CT scanner. 
c. Determinat ion of the diameter of a ca lc i f icat ion. 
We have seen that, because of the part ia l volume e f f e c t , a ball 
w i t h a uniform density is not represented homogenously on the CT 
scan monitor. The HU value of the ball decreases f r o m the centre 
to the edge. 
Subsequently a certain c r i t e r i u m has to be chosen for the determina­
tion of the diameter. Usually the c r i t e r i u m is the "Full width at 
half maximum" (F.W.H.M.). To calculate this F.W.H.M. ( f i g . 4) the 
maximum HU wi th respect to the surrounding tissue has f i r s t to 
be determined. Next, at the value of half this maximum HU value, 
the diameter of the calc i f icat ion is calculated. The advantage of 
this procedure is that this F.W.H.M. diameter does not depend upon 
the HU value i tself. 
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FWHM 
·* *-
FWHM 
Fig. * . schematic representation of the "Full width at half maximum" 
(FWHM) 
d. Determination of the amount of calcium. 
H. Venema (UVA, Amsterdam) has shown, on theoretical grounds, 
that there is a direct relation between the HU value of a calcification 
and its density. He calculated that 1 HU - Λ1 mg Ca/cc. 
In a homogenous ball-shaped calcification with a known diameter 
and a known HU value, which is corrected for the partial volume 
effect, the total amount of calcium can be calculated: 
mg Ca = ^/3 τι r 3 х ^ χ HU Volume χ concentration. 
Table 2 represents the total amount of calcium in a calcification 
having a known (corrected) HU value. 
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3. Procedure to estimate the t o t a l amount of calcium in CT scan-diagnosed 
calci f icat ions 
With the fol lowing procedure i t is possible to estimate the total amount 
of calcium in a calc i f icat ion "seen" at the Delta-FS CT scan monitor: 
1. determine the diameter of the calc i f icat ion at F.W.H.M. 
2. the average HU value of the surface wi th the in " 1 " calculated dia­
meter is determined. 
3. f r o m table 1 the associated HU value is determined· 
k. at the determined diameter and maximum HU value the amount 
of calcium can be read f r o m tabel 2. 
When the diameter of the calc i f icat ion is greater than the slice thicl-ness, 
the maximum value in the centre of the calc i f icat ion can be determined 
direct ly . 
Cerebral calci f icat ions in the stno-pall ido-dentate system are not bal l-
shaped. However, the above described method provides a reasonably 
good evaluation of the calcium content of a cerebral ca lc i f icat ion. 
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DIAM. BALL 
.5 
1 
1.5 
2 
2.5 
3 
3.5 
t 
4.5 
5 
5.5 
6 
6.5 
7 
7.5 
8 
8.5 
9 
9.5 
10 
10.5 
11 
11.5 
12 
12.5 
13 
HU BALL 
150 
37.95 
40.90 
43.85 
46.80 
49.75 
52.70 
55.65 
58.60 
61.55 
64.50 
67.45 
70.40 
73.25 
76.30 
79.25 
82.20 
85.15 
88.10 
91.05 
94.00 
96.94 
99.89 
102.84 
105.79 
108.74 
111.69 
200 
39.23 
43.46 
47.70 
51.93 
56.16 
60.39 
64.63 
68.86 
73.09 
77.32 
81.55 
85.79 
90.02 
94.25 
98.48 
102.72 
106.95 
111.18 
115.41 
119.65 
123.88 
128.11 
132.34 
136.57 
140.81 
145.04 
250 
40.51 
46.03 
51.54 
57.06 
62.57 
68.09 
73.60 
79.12 
84.63 
90.15 
95.66 
101.18 
106.69 
112.21 
117.72 
123.24 
128.75 
134.27 
139.78 
145.30 
150.81 
156.32 
161.84 
167.35 
172.87 
178.38 
300 
41.80 
48.59 
55.39 
62.19 
68.99 
75.78 
82.58 
89.38 
96.18 
102.97 
109.77 
116.57 
123.36 
130.16 
136.96 
143.76 
150.55 
157.35 
164.15 
170.95 
177.74 
184.54 
191.34 
198.13 
204.93 
211.73 
350 
43.08 
51.16 
59.24 
67.32 
75.40 
83.48 
91.56 
99.64 
107.72 
115.80 
123.88 
131.96 
140.04 
148.12 
156.20 
164.28 
172.36 
180.44 
188.52 
196.60 
204.67 
212.75 
220.83 
228.91 
236.99 
245.07 
400 
44.36 
53.72 
63.09 
72.45 
81.81 
91.17 
100.54 
109.90 
119.26 
128.62 
137.98 
147.35 
156.71 
166.07 
175.43 
184.80 
194.16 
203.52 
212.88 
222.25 
231.61 
240.97 
250.33 
259.69 
269.06 
278.42 
45( 
45.64 
56.29 
66.93 
77.58 
88.22 
98.87 
109.51 
120.16 
130.80 
141.45 
152.09 
162.74 
173.38 
184.03 
194.67 
205.32 
215.96 
226.61 
237.25 
247.90 
258.54 
269.18 
279.83 
290.47 
301.12 
311.76 
Table 1. Diameter and maximal HU values of cerebral calcifications, 
calculated for the Delta-FS CT scanner. The underlined values 
represent the diameter of a just barely visible calcification 
with a certain maximal HU value. 
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500 
46.93 
58.85 
70.78 
82.71 
94.64 
106.56 
118.49 
130.42 
142.35 
154.77 
166.20 
178.13 
190.05 
201.98 
213.91 
225.84 
237.76 
249.69 
261.62 
273.55 
285.47 
297.40 
309.33 
321.25 
333.18 
345.11 
600 
49.49 
63.98 
78.48 
92.97 
107.46 
121.95 
136.45 
150.94 
165.43 
179.92 
194.41 
208.91 
223.40 
237.89 
252.38 
266.88 
281.37 
295.86 
310.35 
324.85 
339.34 
353.83 
368.32 
382.81 
397.31 
411.80 
700 
52.06 
69.1 1 
86.17 
103.23 
120.29 
137.34 
154.40 
171.46 
188.52 
205.57 
222.63 
239.69 
256.74 
273.80 
290.86 
307.92 
324.97 
342.03 
359.09 
376.15 
393.20 
410.26 
427.32 
α44.37 
461.43 
478.49 
800 
54.62 
74.24 
93.87 
113.49 
133.11 
152.73 
172.36 
191.98 
211.60 
231.22 
250.84 
270.47 
290.09 
309.71 
329.33 
348.96 
368.58 
388.20 
407.82 
427.45 
447.07 
466.69 
486.31 
505.93 
525.56 
545.18 
900 
57.19 
79.37 
101.56 
123.75 
14 5.94 
168.12 
190.31 
212.50 
234.69 
256.87 
279.06 
301.25 
323.43 
34 5.62 
367.81 
390.00 
412.18 
434.37 
456.56 
478.75 
500.93 
523.12 
545.31 
567.49 
589.68 
611.87 
1000 
59.75 
84.50 
109.26 
134.01 
158.76 
183.51 
208.27 
233.02 
257.77 
282.52 
307.27 
332.03 
356.78 
381.53 
406.28 
ίι31.04 
455.79 
480.54 
505.29 
530.05 
554.80 
579.55 
604.30 
629.05 
653.81 
678.56 
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DIAMETER 
BALL (MM) 
.5 
.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
4.5 
5 
5.5 
6 
6.5 
7 
7.5 
8 
8.5 
9 
9.5 
10 
10.5 
11 
11.5 
12 
12.5 
13 
VOLUME MAXIMAL 
(BALL (MM3) 
0.07 
0.52 
1.77 
4.19 
8.18 
14.14 
22.45 
33.51 
47.71 
65.45 
87. Л 
113.10 
143.79 
179.59 
220.89 
268.08 
321.56 
381.70 
448.92 
523.60 
606.13 
696.91 
796.33 
904.78 
1022.66 
1150.35 
150 
0.02 
0.19 
0.65 
1.53 
2.99 
5.17 
8.21 
12.26 
17.46 
23.95 
31.87 
41.38 
52.61 
65.71 
80.81 
98.08 
117.64 
139.65 
164.24 
191.56 
221.76 
254.97 
291.34 
331.02 
374.14 
420.86 
200 
0.03 
0.26 
0.86 
2.04 
3.99 
6.90 
10.95 
16.35 
23.27 
31.93 
42.49 
55.17 
70.14 
87.61 
107.75 
130.77 
156.86 
186.20 
218.99 
255.41 
295.67 
339.96 
388.45 
441.36 
498.86 
561.15 
HU-VALUE 
250 
0.04 
0.32 
1.08 
2.55 
4.99 
8.62 
13.69 
20.43 
29.09 
39.91 
53.12 
68.96 
87.68 
109.51 
134.69 
163.47 
196.07 
232.75 
273.73 
319.27 
369.59 
424.95 
485.57 
551.70 
623.57 
701.43 
300 
0.05 
0.38 
1.29 
3.06 
5.99 
10.34 
16.43 
24.52 
34.91 
47.89 
63.74 
82.75 
105.21 
131.41 
161.63 
196.16 
235.28 
279.30 
328.48 
383.12 
443.51 
509.94 
582.68 
662.03 
748.29 
841.72 
350 
0.06 
0.45 
1.51 
3.58 
6.98 
12.07 
19.16 
28.61 
40.73 
55.87 
74.37 
96.55 
122.75 
153.31 
188.57 
228.85 
274.50 
325.85 
383.23 
446.98 
517.43 
594.92 
679.79 
772.37 
873.00 
982.01 
400 
0.06 
0.51 
1.72 
4.09 
7.98 
13.79 
21.90 
32.69 
46.55 
63.85 
84.99 
110.34 
140.29 
175.21 
215.51 
261.54 
313.71 
372.39 
437.97 
510.83 
591.35 
679.91 
776.91 
882.71 
997.71 
1122.29 
Table 2. amount of calcium in cerebral calci f icat ions w i t h known (corrected 
for part ia l volume e f f e c t ) HU values. The underlined values repre­
sent the amount of Ca in just barely visible calc i f icat ions. 
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450 
0.07 
0.57 
1.94 
íf.60 
8.98 
15.52 
24.64 
36.78 
52.37 
71.84 
95.61 
124.13 
157.82 
197.12 
242.44 
294.24 
352.93 
418.94 
492.72 
574.68 
665.27 
764.90 
874.02 
993.05 
1122.43 
1262.58 
500 
0.08 
0.64 
2.16 
5.11 
9.98 
17.24 
27.38 
40.87 
58.19 
79.82 
106.24 
137.92 
175.36 
219.02 
269.38 
326.93 
392.14 
465.49 
547.47 
638.54 
739.19 
849.89 
971.13 
1103.39 
1247.14 
1402.86 
600 
0.10 
0.77 
2.59 
6.13 
11.97 
20.69 
32.85 
49.04 
69.82 
95.78 
127.48 
165.51 
210.43 
262.82 
323.26 
392.32 
470.57 
558.59 
656.96 
766.24 
887.02 
1019.87 
1165.36 
1324.07 
1496.57 
1683.44 
700 
0.11 
0.89 
3.02 
7.15 
13.97 
24.14 
38.33 
57.21 
81.46 
111.74 
1^ 8.73 
193.09 
245.50 
306.63 
377.14 
457.70 
549.00 
651.69 
766.45 
893.95 
1034.86 
1189.85 
1359.59 
1544.75 
1746.00 
1964.01 
800 
0.13 
1.02 
3.4 5 
8.17 
15.96 
27.58 
43.80 
65.39 
93.10 
127.71 
169.98 
220.68 
280.57 
350.43 
431.01 
523.09 
627.43 
744.79 
875.94 
1021.66 
1182.70 
1359.83 
1553.81 
1765.43 
1995.43 
2244.58 
900 
0.14 
1.15 
3.88 
9.19 
17.96 
31.03 
49.28 
73.56 
104.74 
143.67 
191.23 
248.26 
315.64 
394.23 
484.89 
588.48 
705.85 
837.89 
985.44 
1149.37 
1330.53 
1529.81 
1748.04 
1986.10 
2244.86 
2525.16 
1000 
0.16 
1.28 
4.31 
10.22 
19.95 
34.48 
54.75 
81.·3 
116.37 
159.63 
212.47 
275.85 
350.72 
438.04 
538.77 
653.86 
784.28 
930.99 
1094.93 
1277.07 
1478.37 
1699.78 
1942.27 
2206.78 
2494.28 
2805.73 
SUMMARY 
Some aspects oí the symptomatology and etiology of fami l ia l calci f icat ions 
in the str io-pal l ido-dentate system have been studied in a father and his 
son wi th autosomal dominant idiopathic hypoparathyroidism, three siblings 
wi th autosomal recessive idiopathic str io-pal l ido-dentate calcinosis (5PDC) 
and in three siblings wi th Cockayne's syndrome. Another study was carried 
out in order to demonstrate the presence of a human cerebral parathyroid-
hormone-responsne adenylcyclase complex. After indications were found 
for its presence, the function of this cerebral PTH responsive adenylcyclase 
complex was studied in a patient w i th autosomal recessive idiopathic 
SPDC and m a patient w i th Cockayne's syndrome. 
The most important results of these investigations are summarized m 
the fol lowing paragraphs. 
1. In the patients wi th autosomal dominant idiopathic hypoparathyroidism 
the extent of the SPDC increased during normocalcemia. This indicates 
that other factors than merely hypocalcemia, influence the cerebral ca l -
c i fy ing process. In f ive patients wi th idiopathic hypoparathyroidism the 
non-specific complex of the somatosensory-evoked potentials (SSEP) was 
disturbed. These findings indicate that CT scan and SSEP might contr ibute 
to the diagnosis and evaluation of hypoparathyroidism and to its therapy. 
2. In the youngest patient w i th autosomal recessive idiopathic SPDC, the 
cerebral calc i f icat ions were located in the dentate nuclei and pons. His 
elder siblings had additional calci f icat ions in the basal ganglia and ra-
diation of the corpus callosum. These calci f icat ions were the most exten-
sive in the eldest. These findings suggest that in autosomal recessive 
idiopathic SPDC the calc i fy ing process is a progressive disorder. I t seems 
to start in the dentate nuclei and pons, and subsequently progresses to 
the basal ganglia and the radiation of the corpus callosum. 
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3. The CT scans of the three siblings wi th Cockayne's syndrome showed 
calci f icat ions in the basal ganglia and dentate nuclei. Their extent in-
creased wi th age, suggesting that in Cockayne's syndrome the calci fy ing 
proces is progresive. The sural nerve biopsies of the three siblings re-
vealed segmental de- and remyelination wi th onion bulb format ion. 
Disturbed visual and brainstem duditory-evoked potentials indicated de-
myelmation of the central nervous system. The peripheral and central 
myelinopathy increased wi th age, suggesting a progressive disorder. These 
observations support the theory of Cockayne's syndrome being a leucodys-
trophy. 
4. There was no correlat ion between the cl inical neurological, c l in ical neuro-
physiological and neuromorphological signs of the patients wi th fami l ia l 
SPDC and the extent and location of the cerebral calci f icat ions. This 
indicates that SPDC is not associated wi th a specific ent i ty of cl inical 
neurological, c l in ical neurophysiological, and/or neuromorphological signs. 
5. In the siblings wi th autosomal recessive idiopathic SPDC and in the siblings 
with Cockayne's syndrome studies on the plasma values of calcium, phos-
phate, parathyroid hormone, calci tonin, cerebrospinal f lu id (CSF) concen-
trat ions of calcium and phosphate, intestinal calcium absorption, radiograms 
of the hands and studies on the influence of parathroid hormone on the 
renal threshold for phosphate and the urinary cAMP concentrations were 
conducted. The results revealed no abnormalit ies suggesting a normal 
calcium-phosphate metabolism in autosomal recessive idiopathic SPDC 
and Cockayne's syndrome. 
6. In three healthy adults the injection of parathyroid hormone (PTH) produced 
d four-to-seven fo ld increase of CSF cAMP concentration. This suggests 
the presence of a cerebral PTH-responsive adenylcyclase complex. 
7. In a patient w i th autosomal recessive idiopathic SPDC and in a patient 
wi th Cockayne's syndrome the influence of PTH on CSF cAMP was studied. 
In the Cockayne's syndrome patient the response was normal. In the SPDC 
patient the response was signif icantly decreased. This f inding suggests 
m 
that a dysfunction of the cerebral adenylcyclase complex is involved m 
the etiology of autosomal recessive idiopathic SPDC. 
8. The most important conclusions of this thesis are: 
I. 1. The neuroradiological sign 'strio-pallido-dentate calcinosis' is a 
sign of cerebral dysfunction. Its presence warrants investigation 
of the calcium-phosphate metabolism, axoxic and toxic factors 
and familial occurence. 
2. The familial neuroradiological sign 'stno-palhdo-dentate calcinosis' 
is not associated with a specific complex of neurological signs. 
II. I. Autosomal recessive idiopathic stno-palhdo-dentate calcinosis and 
Cockayne's syndrome are not associated with a disturbance in the 
calcium-phosphate metabolism. 
2. A human cerebral parathyroidhormone-responsive adenylcyclase 
complex is likely to exist. 
3. Dysfunction of the cerebral parathyroidhormone-responsive adenylcy-
clase complex is probably involved in the etiology of autosomal 
recessive idiopathic strio-pallido-dentate calcinosis. 
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FAMILIAIRE STRIO-PALLIDO-DENTALE VERKALKINGEN 
Enige klinische en etiologische aspecten 
SAMENVATTING 
Enige aspecten van de sympomatologie en etiologie van fami l iare verkal-
kingen in het str io-palhdo-dentale systeem (SPDC) werden onderzocht 
bij een vader en zijn zoon met autosomaal dominante idiopathische hypo-
parathyreoidie (IHPT), twee mannen en een vrouw, ui t één gezin, met 
autosomaal recessive idiopathische SPDC en twee jongens en een meisje, 
u i t één gezin, met het syndroom van Cockayne. Tevens werd een onderzoek 
verr icht , om het bestaan van een cerebraal parathormoongevoelig adenylcy-
clase complex aan te kunnen tonen. Nadat aanwijzingen waren gevonden 
voor het bestaan hiervan, werd de werking van di t cerebraal parathormoon-
gevoelig adenylcyclase complex onderzocht bij een patiente met autosomaal 
recessieve idiopathische SPDC en bij een patient met het syndroom van 
Cockayne. 
De belangrijkste resultaten van deze onderzoekingen worden in de volgende 
paragrafen samengevat. 
1. Bi j de patiënten met autosomaal dominante IHPT nam de grootte van 
de SPDC toe, te rw i j l de calcium concentrat ie in het serum normaal was. 
D i t wi jst erop dat méér factoren, dan alleen een te lage plasma calsium 
concentrat ie, invloed hebben op de toename van de SPDC. Bij patiënten 
met autosomaal dominante IHPT en bij 3 andere patiënten met sporadische 
IHPT was het met-specif ieke complex van de somatosensory evoked po-
tentials (SSEP) abnormaal. Deze bevindingen wijzen erop dat CT scan 
en SSEP onderzoeken een bijdrage kunnen leveren aan de diagnostiek en 
de evaluatie van hypoparathyreoidie, te rw i j l deze onderzoeken mogelijk 
ook een bijdrage kunnen leveren aan de evaluatie van de therapie van 
di t ziektebeeld. 
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2. Bij de jongste patient met autosomaal recessieve idiopathische SPDC be-
vonden de verkalkingen zich in de nuclei dentat i en de pons, terwi j l zi jn 
oudere broer en zus bovendien verkalkingen hadden in de basale ganglia 
en radiat io van het corpus callosum. Deze verkalkingen waren het grootst 
bij de oudste pat iente. Deze bevindingen suggereren dat bij autosomaal 
recessieve idiopathische SPDC de verkalkingen het eerst ontstaan in de 
nuclei dentat i en pons, te rw i j l in een later studium ook verkalkingen ont-
staan in de basale ganglia en de radiatio van het corpus callosum. 
3. De drie patiënten met het syndroom van Cockayne hadden allen verkalkingen 
in de basale ganglia en de nuclei dentat i . Bi j de jongste waren deze verkal-
kingen het kleinst, bij de oudste het grootst. D i t wi jst erop dat de SPDC 
toeneemt bij patiënten met het syndroom van Cockayne. Nervus surahs 
biopten van de drie kinderen met het syndroom van Cockayne l ieten segmen-
tale de- en remyelinisatie met omon-bulbs zien, te rw i j l gestoorde visual-
en brainstem auditory-evoked potentials wezen op demyelimsatie in het 
centrale zenuwstelsel. Deze perifere en centrale demyelimsatie nam toe 
met de leef t i jd van de patiënten. D i t suggereert dat de demyelimsatie 
bij het syndroom van Cockayne progressief is. De bevindingen steunen 
de theorie, dat het syndroom van Cockayne behoort tot de groep van 
leudodysstrofieën. 
k. Bij de patiënten met fami l ia i re SPDC konden wi j geen verband aantonen 
tussen de aanwezigheid van cerebrale verkalkingen en het optreden van 
bepaalde klinisch neurologische, klinisch neurofysiologische en/of neuro-
morfologische verschijnselen. Di t wi jst erop dat SPDC niet pepaard gaat 
met een kenmerkend klinisch neurologisch, klinisch neurofysiologisch en/of 
neuromorfologisch symptomen complex. 
5. Bij patiënten met autosomaal recessieve idiopathische SPDC en bij patiënten 
met het syndroom van Cockayne waren de plasma concentraties van calc ium, 
fosfaat, parathormoon, calcitonine en de liquor concentraties van calcium 
en fosfaat normaal. Ook de intestinale calcium absorptie, röntgenfoto's 
van de handen en het ef fect van parathormoon op de nierdrempel voor 
fosfaat en op de cyclisch AMP concentratie m de urme waren ongestoord. 
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Deze bevindingen wijzen erop dat het calcium-fosfaat metabolisme bij 
autosomaal recessieve idiopathische SPDC en het syndroom van Cockayne 
met gestoord is. 
6. Bij drie gezonde proefpersonen veroorzaakte de intraveneuze toediening 
van parathormoon een vier- tot zevenvoudige toename van de liquor cyclisch 
AMP concentrat ie. D i t suggereert de aanwezigheid van een cerebraal 
parathormoon gevoelig adenylcyclase complex. 
7. Het functioneren van het cerebraal parathormoon-gevoelig adenylcyclase 
complex werd onderzocht bij een patient met het syndroom van Cockayne 
en bij een patient met autosomaal recessieve idiopathische SPDc. Bi] 
de patient met het syndroom van Cockayne veroorzaakte parathormoon 
een normale toename van de liquor cyclisch AMP concentrat ie. Bij de 
patiente met autosomaal recessieve idiopathische SPDC steeg de liquor 
cyclisch AMP concentrat ie onvoldoende. Deze bevindingen suggereren 
dat het cerebraal parathormoon-gevoelig adenylcyclase complex normaal 
funct ioneert bij het syndroom van Cockayne, t e r w i j l bi j autosomaal reces­
sieve idiopathische SPDC de funct ie hiervan gestoord is. Mogelijk speelt 
een verminderde gevoeligheid van het cerebraal parathormoon gevoelig 
adenylcyclase complex een rol bi j het ontstaan van autosomaal recessieve 
idiopathische SPDC. 
8. De belangrijkste konklusies van di t proefschrift z i jn: 
I. 1. N e u r o r a d i o l o g i s c h aantoonbare strio-pall ido-dentale verkalkingen 
wijzen op een gestoorde hersenfunctie en kunnen aanleiding geven 
tot onderzoek naar stoornissen in de calcium-fosfaat stofvnsseling, 
anoxische en toxische faktoren en naar een fami l ia i r voorkomen 
van deze verkalkingen. 
2. Famil iair voorkomende neuroradiologisch aantoonbare stno-pal l ido-
dentale verkalkingen gaan niet gepaard met kenmerkende neurologische 
verschijnselen. 
Π. 1. Autosomaal recessieve idiopathische strio-pall ido-dentale verkalkingen 
en het syndroom van Cockayne gaan met gepaard met een gestoorde 
calcium-fosfaat stofwisseling. 
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2. In de menselijke hersenen bevindt zich waarschijnli jk een voor para-
thormoon gevoelig adenylcyclase complex. 
3. Een stoornis in het cerebrale parathormoon-gevoehg adenylcyclase-
complex is vermoedeli jk betrokken bij het onstaan van auto^onaal 
recessieve idiopathische stno-pal l ido-dentale verkalkingen. 
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STELLINGEN 
Behorende bij het proefschrift 
FAMILIAL STRIO-PALLIDO-DENTATE CALCINOSIS 
SOME CLINICAL AND ETIOLOGICAL ASPECTS 
In het openbaar te verdedigen 
op 2 maart 1984 
des namiddags te 4 uur 
door 
NLG. SMITS 
I 
Verkalkmgeii in het stno-pallido-dentale systeem wijzen op een functie-
stoornis van de hersenen. 
- dit proefschrift. 
II 
Verkalkingen in het strio-pallido-dentale systeem gaan niet gepaard met 
kenmerkende neurologische verschijnselen. 
- dit proefschrift. 
III 
Dierexperimenteel onderzoek zal informatie kunnen geven over de functie 
en locahsatie van het cerebrale, parathormoongevoelige, andenylcyclase-
complex. 
- dit proefschrift. 
IV 
Het is zinvol verder onderzoek te verrichten naar de functie van het 
cerebrale, parathormoongevoelige, adenylcyclase-complex bij patiënten 
met verkalkingen in het strio-pallido-dentale systeem. 
- dit proefschrift. 
V 
Het syndroom van Cockayne is een vorm van leukodystrofie. 
- Moosa en Dubowitz: Arch. Dis. Child. <t5:674-677; 1970. 
VI 
Elke patient met een onbegrepen mentale retardatie heeft recht op een 
uitvoerig neurologisch onderzoek. 
VII 
Elke diagnostische ingreep die geen therapeutische consequenties heeft, 
is een wetenschappelijk onderzoek of experiment en dient te worden omge-
ven met alle daarbij behorende reserves en maatregelen. 
- Robin E.R.: 3.A.M.A. 240:2273-2275, 1978. 
Vili 
Het is zinvol bij iedere patient met onbegrepen epileptische verschijnselen 
de concentratie van calcium en fosfaat in "nuchter afgenomen" bloed 
te bepalen. 
- Guberman A. Epilepsia 20:541-553, 1979. 
IX 
Bij de diagnostiek van vaatwandleasies in de halsarteriën heeft intraveneuze 
digitale subtractie-angiografie in het algemeen de voorkeur boven conventio-
nele catheter angiografie. 
- de Vries A.J.R. Proefschrift, Amsterdam 1984. 
X 
Therapie bij metabole spierziekten dient voorafgegaan te worden door 
uitvoerige moleculaire diagnostiek. 
XI 
Het kennen van variaties in de normale psycho-motore ontwikkeling van 
het kind is onmisbaar bij het herkennen van een gestoorde ontwikkeling. 
XII 
Kinderen met onbegrepen leerstoornissen hebben recht op uitvoerig didac-
tisch, neuropsychologisch en kinderneurologisch onderzoek. 
XIII 
Het "promoveren op artikelen" dient krachtig gestimuleerd te worden. 
XIV 
Het blijft een onopgeloste vraag of verkalkingen in de gezondheidszorg 
vaker voorkomen dan verkalkingen in de hersenen. 



